Division of Hematopoietic Disease Control,
Institute of Medical Science, The University of Tokyo

年を選択すると、各年の発表論文一覧へ移動します。

Publications

2026

  1. Andoh, S., S. Kato, J. Ooi, M. Monna-Oiwa, J. Kuroda, H. Ichimura, K. Kondo, Y. Nannya, S. Takahashi, and T. Konuma, Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies. Transplant Cell Ther, 2026. 32(3): p. 337 e1-337 e13.
  2. Bewersdorf, J.P., T. Kewan, L. Lanino, W. Wei, T. Rudra Gupta, J.M. Stempel, N.H. Al Ali, A.E. DeZern, M.A. Sekeres, G.L. Uy, S. Urrutia, H.E. Carraway, P. Desai, E.A. Griffiths, E.M. Stein, A.M. Brunner, C. McMahon, R.M. Shallis, J.F. Zeidner, M.R. Savona, H. Hawkins, N.S. Chandhok, C.N. Logothetis, A. Bidikian, T.M. Getz, G.J. Roboz, B. Rolles, E.S. Wang, A.C. Harris, M.L. Amaya, S. Ball, J. Grenet, Z. Xie, Y.F. Madanat, Y. Abaza, T. Badar, J. Campos, T. Haferlach, J.P. Maciejewski, D. Sallman, A. Enjeti, K. Al-Rabi, K. Halahleh, D. Hiwase, M. Diez-Campelo, D. Valcarcel, C. Haferlach, L. Pleyer, I. Kotsianidis, V. Pappa, V. Santini, A. Consagra, A. Al-Kali, S. Ogawa, Y. Nannya, M. Stahl, M.G. Della Porta, R.S. Komrokji, and A.M. Zeidan, Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database. Blood Cancer J, 2026.
  3. Chonabayashi, K., M. Iwasaki, J. Kanda, H. Takamori, A. Yoda, T. Kawata, S. Mizuta, M. Sakurada, T. Kondo, N. Hiramoto, Y. Ueda, A. Gotoh, M. Watanabe, S. Kasahara, Y. Ishikawa, H. Kiyoi, K. Imada, K. Mitani, T. Kitano, N. Arima, Y. Nakabo, N. Sezaki, N. Kanemura, T. Fukuda, M. Ichikawa, Y. Miyazaki, S. Fuji, M. Sakata-Yanagimoto, Y. Yoshida, A. Takaori-Kondo, S. Ogawa, and Y. Nannya, NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners. Leukemia, 2026. 40(3): p. 491-501.
  4. Gurnari, C., H. Makishima, A. Durmaz, E. Attardi, R. Saiki, A. Bataller, G. Sapinho, L. Gondek, Y. Nannya, S. Best, P. Krishnamurthy, K.L. Kong, Y. Atsuta, S. Kasahara, K. Ohyashiki, Y. Miyazaki, N. Kanemura, N. Hiramoto, F. Versino, M.J. Montoro, S. Torres-Esquius, A. Jerez Cayuela, M. Lopez-Esteban, C. Martinez-Laperche, H. Awada, V. Visconte, C.D. DiNardo, M.T. Voso, A.E. DeZern, G. Garcia-Manero, A.G. Kulasekararaj, J.P. Maciejewski, and S. Ogawa, DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study. Leukemia, 2026. 40(1): p. 178-187.
  5. Habano, E., M. Ogawa, K. Watanabe, N. Akiyama, H. Chang, M. Ka, A. Shinozaki-Ushiku, M. Tanabe, M. Akahori, T. Ichijo, S. Tsutsumi, K. Tatsuno, H. Aburatani, H. Kage, and K. Oda, Germline pathogenic variants detected by GenMineTOP: insight from a nationwide tumor/normal paired comprehensive genomic profiling test, in Japan. J Hum Genet, 2026. 71(1): p. 1-11.
  6. Hosoi, H., I. Tanigawa, T. Nouchi, M. Sogabe, K. Tanaka, S. Murata, S.I. Murata, A. Sato, and T. Sonoki, Detection of BRAF V600E on the Re-evaluation in Erdheim-Chester Disease with Prior Negative Testing. Intern Med, 2026.
  7. Ichimura, H., S. Kato, M. Monna-Oiwa, S. Andoh, J. Kuroda, K. Kondo, Y. Nannya, S. Takahashi, and T. Konuma, Comparative analysis of the acute myeloid leukemia-composite model and treatment-related mortality score in single-unit cord blood transplantation. Leuk Lymphoma, 2026. 67(1): p. 229-232.
  8. Jimbo, K., A. Ito, E. Horibe, N. Yagishita, J. Makiyama, H. Itonaga, T. Miyazono, K. Nosaka, M. Yoshimitsu, I. Choi, N. Kawano, K.R. Koh, E. Otsuka, H. Nakashima, Y. Yamano, Y. Nannya, T. Fukuda, and A.T.L.C. Japan Aggressive, Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationwide registry analysis. Blood Cancer J, 2026.
  9. Kato, S., M. Monna-Oiwa, S. Andoh, H. Ichimura, J. Kuroda, K. Kondo, Y. Nannya, S. Takahashi, and T. Konuma, Clinical impact of pre-transplant estimated glomerular filtration rate using the CKD-EPI equation with serum creatinine on outcomes after single-unit cord blood transplantation in adults. Leuk Lymphoma, 2026. 67(8): p. 1829-1832.
  10. Kohso, A., S. Iwamoto, K. Niwa, Y. Nannya, T. Toki, R. Hanaki, H. Toyoda, T. Deguchi, S. Ogawa, K. Terui, E. Ito, and M. Hirayama, Detection of clonal selection by multicolor flow cytometry in TAM with multiple GATA1 mutations. Int J Hematol, 2026. 123(2): p. 297-301.
  11. Konuma, T., M. Hamatani-Asakura, S. Kato, S. Andoh, H. Ichimura, J. Kuroda, K. Kondo, K. Yokoyama, M. Monna-Oiwa, Y. Nannya, and S. Takahashi, Toll-Like Receptor Polymorphisms Influence Graft-Versus-Host Disease and Infection Risk After Single-Unit Cord Blood Transplantation for Adults. Eur J Haematol, 2026. 116(1): p. 37-45.
  12. Konuma, T., M. Hamatani-Asakura, S. Kato, S. Andoh, H. Ichimura, J. Kuroda, K. Kondo, K. Yokoyama, M. Monna-Oiwa, Y. Nannya, and S. Takahashi, Recipient polymorphism of the C-reactive protein (CRP) gene rs2794521 stratified disease-free survival, but did not influence maximum serum CRP levels during neutropenia after single-unit cord blood transplantation in adults. Leuk Lymphoma, 2026. 67(5): p. 1177-1180.
  13. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, S. Andoh, H. Ichimura, K. Yokoyama, Y. Nannya, and S. Takahashi, Clinical impact of glucocorticoid responsiveness-related gene polymorphism on graft-versus-host disease and survival after single-unit cord blood transplantation. Int J Hematol, 2026. 123(3): p. 412-420.
  14. Konuma, T., Y. Shimomura, S. Yamasaki, T. Kondo, N. Uchida, M. Tanaka, S. Takahashi, K. Ogura, A. Wake, T. Kuriyama, S. Takada, T. Izumi, Y. Kozai, Y. Uehara, M. Tokunaga, N. Hattori, Y. Katayama, K. Kawamura, F. Ishimaru, J. Kanda, M. Ohbiki, Y. Atsuta, and M. Yanada, Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for Non-Remission Acute Myeloid Leukemia? Transplant Cell Ther, 2026.
  15. Kurashige, M., A. Hino, K. Muto, K. Nagahama, T. Yamamoto, K. Nakata, M. Ichii, K. Fukushima, K. Karube, Y. Nannya, N. Hosen, S. Ogawa, and E. Morii, Primary gastric EBV-positive cytotoxic-molecule-negative T-cell lymphoma with TET2 multihit mutations: a case report. J Clin Exp Hematop, 2026. 66(1): p. 85-90.
  16. Kurita, N., K. Maruo, F. Kimura, Y. Kuwatsuka, T. Matsukawa, T. Konuma, S. Kobayashi, M. Sakata-Yanagimoto, N. Doki, M. Tanaka, N. Uchida, T. Nishida, M. Sawa, Y. Hasegawa, H. Nakamae, S. Ota, M. Onizuka, T. Fukuda, N. Hiramoto, T. Kawakita, N. Asada, F. Ishimaru, J. Kanda, K. Tabuchi, Y. Atsuta, H. Nakasone, Donor/Source, T. Transplant Complications Working Groups of the Japanese Society for, and T. Cellular, Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study. Am J Hematol, 2026. 101(1): p. 193-197.
  17. Kynning, M.K., E. Westerberg, L. Forsell, M. Creignou, D.M. Berggren, B. Tesi, E. Bernard, E. Papaemmanuil, Y. Nannya, L.C. Franco, D. Valentini, E.H. Lindberg, S. Ogawa, E. Ejerblad, and J. Ungerstedt, Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study. Br J Haematol, 2026. 208(2): p. 514-523.
  18. Mimura, K., A. Kaino, Y. Ochi, Y.H. Chang, M. Seki, J. Takeda, S. Katayama, H. Niizuma, Y. Sasahara, Y. Mizoguchi, M. Shimomura, R. Koyamada, R. Ono, D. Hasegawa, K. Mitani, H. Kubota, S. Yoshihara, N. Hiramoto, A. Otsuki, Y. Okamura, F. Katsuoka, K. Kinoshita, M. Hasegawa, M. Togo-Ohno, H. Maeda, N. Kakiuchi, M. Takeuchi, A. Sato-Otsubo, S. Kato, K. Watanabe, K. Katayama, S. Imoto, Y. Shiraishi, K. Koh, S. Suenobu, E. Hiyama, S. Goyama, A. Kikuchi, S. Ogawa, M. Kato, Y. Nannya, J. Takita, and K. Yoshida, BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL. Blood, 2026. 148(3): p. 335-347.
  19. Nagae, K., H. Muranushi, Y. Nannya, and T. Maeda, Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report. Clin Hematol Int, 2026. 8(2): p. 40-49.
  20. Nishimura, K., T. Isobe, T. Shigehiro, M. Nomura, W. Zang, M. Xiao, W. Liao, Y. Koike, A. Nishimura, A. Sato-Otsubo, H. Yamazaki, H. Ito, S. Okada, N. Matsumoto, W. Saika, Y. Zhang, Y. Aoyama, C. Hasegawa, T. Yamasaki, Y. Kubota, K. Ohki, N. Kiyokawa, G. Nagae, K. Yoshida, Y. Nannya, H. Ueno, S. Fukuda, K. Tatsuno, S. Tsutsumi, Y. Shiozawa, Y. Shiraishi, K. Chiba, H. Tanaka, M. Eguchi, Y. Arakawa, K. Koh, T. Deguchi, D. Tomizawa, T. Miyamura, E. Ishii, S. Mizutani, S. Miyano, H. Aburatani, S. Ogawa, A. Takaori-Kondo, A. Yokoyama, O. Abdel-Wahab, P. Ernst, J. Takita, T. Ikawa, M. Takagi, and D. Inoue, Comprehensive molecular and functional analysis of NUTM1-rearranged leukemia. Blood, 2026. 147(13): p. 1395-1411.
  21. Ochi, Y., M. Liew-Littorin, Y. Nannya, S. Bengtzen, B. Piauger, S. Deneberg, M. Jadersten, V. Lazarevic, J. Cammenga, A. Robelius, L. Wennstrom, E. Olander, S. Kasahara, N. Hiramoto, N. Kanemura, N. Sezaki, M. Sakurada, M. Iwasaki, J. Kanda, Y. Ueda, S. Yoshihara, T. Erkers, N. Struyf, Y. Watanabe, M. Motomura, M.M. Nakagawa, R. Saiki, H. Fukushima, K. Okazaki, S. Morimoto, A. Yoda, R. Okuda, S. Komatsu, G. Xie, A. Osterroos, A. Kon, L. Zhao, Y. Shiraishi, T. Ishikawa, S. Miyano, K. Katayama, S. Imoto, S. Matsuda, A. Takaori-Kondo, H. Aburatani, H.I. Suzuki, O. Kallioniemi, G. Juliusson, M. Hoglund, S. Lehmann, and S. Ogawa, Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia. Nature, 2026.
  22. Okamoto, Y., H. Arima, K. Ishiyama, K. Chonabayashi, J. Kanda, K. Yamashita, M. Fujimoto, H. Haga, Y. Nannya, S. Ogawa, and A. Takaori-Kondo, A diagnostic pitfall in cold agglutinin disease: KMT2D-mutated CAD-associated lymphoproliferative disorder with a CLL-like immunophenotype. Oxf Med Case Reports, 2026. 2026(5): p. omag061.
  23. Okamoto, Y., K. Ishiyama, K. Chonabayashi, J. Kanda, M. Kawai, A. Fukuda, Y. Nannya, S. Ogawa, K. Yamashita, and A. Takaori, T-cell large granular lymphocyte leukaemia with pure red cell aplasia harbouring a somatic STAT3 P715L mutation. BMJ Case Rep, 2026. 19(6).
  24. Okuda, T., Y. Hanyu, H. Mineshige, Y. Inoue, M. Sakurada, M. Matsui, N. Katsuki, M. Iwasaki, J. Takeda, J. Kanda, Y. Nannya, S. Ogawa, A. Takaori-Kondo, Y. Miyahara, and M. Itoh, Severe aplastic anemia concurrent with lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: A case report. Intern Med, 2026.
  25. Sakashita, M., J. Kanda, K. Hattori, N. Hiramoto, N. Kanemura, S. Kasahara, M. Watanabe, S. Yoshihara, M. Ichii, N. Sezaki, M. Tsuji, T. Maeda, K. Sasaki, T. Kitano, Y. Miyahara, T. Kondo, M. Sakata-Yanagimoto, A. Takaori-Kondo, S. Ogawa, and Y. Nannya, Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes. Blood Cancer J, 2026. 16(1).
  26. Sato, A., N. Yusa, H. Takamori, E. Shimizu, K. Jimbo, S. Kato, T. Konuma, K. Yokoyama, S. Imoto, S. Takahashi, and Y. Nannya, Common ancestral origin of indeterminate dendritic cell tumor and chronic myelomonocytic leukemia in clonal hematopoiesis. Haematologica, 2026. 111(5): p. 1885-1890.
  27. Sato, K., Y. Zaimoku, Y. Kano, M. Kobayashi, S. Kazama, T. Morikawa, H. Kazumoto, W. Ishii, T. Ueki, M. Sumi, H. Kobayashi, Y. Nannya, S. Ogawa, and N. Ichikawa, Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report. Front Immunol, 2026. 17: p. 1841156.
  28. Takamori, H., Y. Ueda, Y. Matsuoka, T. Fujioka, N. Yusa, K. Yokoyama, H. Makishima, Y. Murakami, T. Kinoshita, S. Imoto, S. Miyano, Y. Kanakura, J.I. Nishimura, N. Hosen, S. Ogawa, and Y. Nannya, Lifelong phylogenetic reconstruction of immune-mediated clonal trajectories in paroxysmal nocturnal hemoglobinuria. Leukemia, 2026.
  29. Yamagata, F., K. Yoshihara, Y. Nannya, M. Samori, S. Takahashi, T. Kumamoto, Y. Fujita, N. Utsunomiya, and S. Yoshihara, Early Transplantation After Pretransplant Reduction of TP53-Altered Clones and Prolonged Dose-Adjusted Azacitidine Maintenance: A Three-Case Series. EJHaem, 2026. 7(3): p. e70315.
  30. Yokoyama, K., N. Yusa, K. Jimbo, A. Takahashi, K. Ogami, E. Shimizu, S. Imoto, T. Nagamura-Inoue, and Y. Nannya, Sustained molecular clearance of the MYD88 p.L265P-mutant clone preceding resolution of cold agglutinin syndrome after autologous stem cell transplantation. Haematologica, 2026.

Back to top ↑

Publications

2025

  1. Andoh, S., S. Kato, J. Ooi, M. Monna-Oiwa, J. Kuroda, H. Ichimura, K. Kondo, Y. Nannya, S. Takahashi, and T. Konuma, Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies. Transplant Cell Ther, 2025.
  2. Arai, S., K. Matsumoto, H. Tashiro, S. Kato, T. Konuma, and J. Ooi, Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia. Blood Cell Ther, 2025. 8(3): p. 225-227.
  3. Furukawa, S., A. Ito, K. Jimbo, M. Sakashita, S. Harada, M. Nagata, T. Fujii, A. Usui, M. Watanabe, W. Takeda, T. Hirakawa, K. Yokoyama, A. Sato, M. Yamagishi, K. Uchimaru, Y. Nannya, and T. Fukuda, Bridging therapy with valemetostat to allogeneic hematopoietic cell transplantation for adult T-cell leukemia/lymphoma. J Clin Exp Hematop, 2025. 65(3): p. 180-184.
  4. Gurnari, C., H. Makishima, A. Durmaz, E. Attardi, R. Saiki, A. Bataller, G. Sapinho, L. Gondek, Y. Nannya, S. Best, P. Krishnamurthy, K.L. Kong, Y. Atsuta, S. Kasahara, K. Ohyashiki, Y. Miyazaki, N. Kanemura, N. Hiramoto, F. Versino, M.J. Montoro, S. Torres-Esquius, A. Jerez Cayuela, M. Lopez-Esteban, C. Martinez-Laperche, H. Awada, V. Visconte, C.D. DiNardo, M.T. Voso, A.E. DeZern, G. Garcia-Manero, A.G. Kulasekararaj, J.P. Maciejewski, and S. Ogawa, DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study. Leukemia, 2025.
  5. Hata, R., S. Funakoshi, T. Makiyama, T. Kato, M. Narita, Y. Matsumura, R. Hirohata, Y. Naka, K. Ida, H. Ito, A. Yoshizawa, Y. Nannya, H. Haga, S. Ogawa, K. Ono, T. Kimura, and Y. Yoshida, Integrative Transcriptomic-Histological Analysis in Dilated Cardiomyopathy Unveils FGFR1 Inhibition as Anti-Cardiac Fibrotic and Cardioprotective Therapy. JACC Basic Transl Sci, 2025. 10(10): p. 101363.
  6. Ichimura, H., S. Kato, M. Monna-Oiwa, S. Andoh, J. Kuroda, K. Kondo, Y. Nannya, S. Takahashi, and T. Konuma, Comparative analysis of the acute myeloid leukemia-composite model and treatment-related mortality score in single-unit cord blood transplantation. Leuk Lymphoma, 2025: p. 1-4.
  7. Ikoma, Y., N. Nakamura, Y. Kaneda, H. Takamori, T. Seki, N. Hiramoto, J. Kitagawa, J. Kanda, K. Fujita, T. Morishita, Y. Ochi, S. Chiba, N. Sasaki, M. Ichii, K. Imada, M. Watanabe, M. Hishizawa, Y. Miyahara, Y. Maesako, Y. Tanaka, S. Oka, M. Tsuji, S. Yoshihara, K. Mitani, Y. Ueda, T. Kitano, M. Watanabe, N. Sezaki, T. Kondo, S. Kasahara, A. Takaori-Kondo, N. Kanemura, S. Ogawa, and Y. Nannya, Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML. Leukemia, 2025. 39(6): p. 1362-1367.
  8. Imashuku, S., Y. Kazuma, K. Chonabayashi, Y. Shimazu, J. Kanda, Y. Nannya, S. Ogawa, and N. Anzai, Myelodysplastic syndrome with ring chromosomes in a case of dehydrated hereditary stomatocytosis 1 (DHS1). Int J Hematol, 2025. 121(6): p. 857-861.
  9. Jimbo, K., T. Ishigaki, M. Sakashita, S. Andoh, H. Ichimura, A. Ito, K. Yokoyama, A. Sato, T. Fukuda, K. Uchimaru, and Y. Nannya, Prognosis of aggressive adult T-cell leukemia/lymphoma with central nervous system infiltration and utility of CD7 versus CADM1 flowcytometric plots of cerebrospinal fluid. Ann Hematol, 2025. 104(1): p. 635-640.
  10. Jimbo, K., A. Ito, H. Ichimura, J. Kuroda, S. Andoh, A. Sato, K. Yokoyama, T. Fukuda, K. Uchimaru, and Y. Nannya, Prognostic impact of organ involvement in aggressive adult T-cell leukemia/lymphoma: definition of risk organ and proposal of a prognostic index. Blood Cancer J, 2025. 15(1): p. 166.
  11. Jimbo, K., M. Nojima, K. Toriuchi, M. Yamagishi, M. Nakashima, Y. Yamano, K. Uchimaru, and Y. Nannya, Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma. Biomark Res, 2025. 13(1): p. 34.
  12. Kato, S., M. Monna-Oiwa, S. Andoh, Y. Oda, Y. Nannya, S. Takahashi, and T. Konuma, The Composite Health Risk Assessment Model (CHARM) Predicts Overall Mortality and Relapse, But Not Non-Relapse Mortality, in Adults Following Unrelated Single-Unit Cord Blood Transplantation. Turk J Haematol, 2025. 42(3): p. 181-195.
  13. Kawai, H., H. Fukushima, Y. Nannya, M. Onizuka, Y. Ogawa, and H. Kawada, Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report. Int J Hematol, 2025.
  14. Kogure, Y., Y. Oshikawa-Kumade, S. Fukuhara, K. Chiba, A. Okada, M. Kato, Y. Nannya, M. Sakata-Yanagimoto, M. Ri, T. Maeda, H. Muramatsu, T. Ishikawa, M. Sanada, Y. Ueda, D. Ennishi, R. Higashiyama, D. Koga, Y. Shiraishi, K. Izutsu, and K. Kataoka, [Development and performance evaluation of a comprehensive genomic profiling assay for hematological malignancies]. Rinsho Ketsueki, 2025. 66(7): p. 693-704.
  15. Kohso, A., S. Iwamoto, K. Niwa, Y. Nannya, T. Toki, R. Hanaki, H. Toyoda, T. Deguchi, S. Ogawa, K. Terui, E. Ito, and M. Hirayama, Detection of clonal selection by multicolor flow cytometry in TAM with multiple GATA1 mutations. Int J Hematol, 2025.
  16. Konuma, T., M. Fujioka, K. Fuse, H. Hosoi, Y. Masamoto, N. Doki, N. Uchida, M. Tanaka, M. Sawa, T. Nishida, J. Ishikawa, N. Asada, H. Nakamae, Y. Hasegawa, M. Onizuka, T. Maeda, T. Fukuda, K. Kawamura, Y. Kanda, M. Ohbiki, Y. Atsuta, and H. Itonaga, Clinical effects of granulocyte colony-stimulating factor administration and the timing of its initiation on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndrome. Transplant Cell Ther, 2025. 31(6): p. 388 e1-388 e14.
  17. Konuma, T., M. Hamatani-Asakura, S. Kato, S. Andoh, H. Ichimura, J. Kuroda, K. Kondo, K. Yokoyama, M. Monna-Oiwa, Y. Nannya, and S. Takahashi, Toll-Like Receptor Polymorphisms Influence Graft-Versus-Host Disease and Infection Risk After Single-Unit Cord Blood Transplantation for Adults. Eur J Haematol, 2025.
  18. Konuma, T., M. Hamatani-Asakura, S. Kato, S. Andoh, H. Ichimura, J. Kuroda, K. Kondo, K. Yokoyama, M. Monna-Oiwa, Y. Nannya, and S. Takahashi, Recipient polymorphism of the C-reactive protein (CRP) gene rs2794521 stratified disease-free survival, but did not influence maximum serum CRP levels during neutropenia after single-unit cord blood transplantation in adults. Leuk Lymphoma, 2025: p. 1-4.
  19. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, S. Andoh, H. Ichimura, K. Yokoyama, Y. Nannya, and S. Takahashi, Clinical impact of glucocorticoid responsiveness-related gene polymorphism on graft-versus-host disease and survival after single-unit cord blood transplantation. Int J Hematol, 2025.
  20. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, S. Andoh, Y. Oda, K. Yokoyama, Y. Nannya, and S. Takahashi, Risk of acute graft-versus-host disease in recipients with IL-10 promoter polymorphism rs1800872, but not IL-10 receptor beta polymorphism rs2834167, after single-unit cord blood transplantation. Hum Immunol, 2025. 86(4): p. 111322.
  21. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, M. Isobe, K. Yokoyama, Y. Nannya, and S. Takahashi, Higher relapse and worse overall survival in recipients with CTLA-4 AA genotype of rs231775 following single-unit cord blood transplantation in adults. Leuk Lymphoma, 2025. 66(4): p. 733-743.
  22. Konuma, T., M. Hamatani-Asakura, E. Nagai, S. Kato, S. Andoh, E. Adachi, M. Monna-Oiwa, S. Takahashi, H. Yotsuyanagi, and Y. Nannya, Assessment of cellular and humoral immunity against varicella-zoster virus in adult allogeneic hematopoietic cell transplant recipients: a cross-sectional study assessing cellular immunity after administration of an adjuvanted recombinant zoster vaccine. J Infect Chemother, 2025. 31(12): p. 102857.
  23. Konuma, T., K. Kameda, K. Morita, T. Kondo, F. Kimura, H. Nakasone, F. Ouchi, N. Uchida, M. Tanaka, T. Nishida, T. Fukuda, Y. Hasegawa, M. Sakata-Yanagimoto, M. Onizuka, M. Sawa, S. Ota, N. Asada, S.I. Fujiwara, S. Yoshihara, F. Ishimaru, M. Yoshimitsu, Y. Kanda, M. Ohbiki, Y. Atsuta, and M. Yanada, Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft type. Am J Hematol, 2025. 100(1): p. 66-77.
  24. Konuma, T., J. Kanda, N. Uchida, M. Tanaka, F. Kimura, H. Nakasone, Y. Uehara, M. Tokunaga, M. Toyosaki, S. Miyakoshi, N. Doki, K. Ishiwata, H. Kobayashi, Y. Onishi, Y. Kozai, K. Kato, F. Ishimaru, T. Fukuda, Y. Atsuta, and S. Takahashi, Has early mortality following single-unit unrelated cord blood transplantation improved in recent years? A nationwide registry data analysis from 2003 to 2022 in Japan. Br J Haematol, 2025. 207(5): p. 2026-2040.
  25. Konuma, T., M. Monna-Oiwa, S. Kato, M. Isobe, S. Takahashi, and Y. Nannya, Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults. Acta Haematol, 2025. 148(3): p. 258-268.
  26. Konuma, T., Y. Shimomura, S. Mizuno, S. Yamasaki, S. Yui, N. Uchida, N. Doki, M. Tanaka, S. Yoshihara, T. Eto, Y. Katayama, Y. Katsuoka, M. Tokunaga, S. Ota, M. Sakata-Yanagimoto, K. Ishiwata, Y. Kanda, T. Kawakita, M. Onizuka, J. Kanda, T. Fukuda, Y. Atsuta, and M. Yanada, Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy. Br J Haematol, 2025. 207(2): p. 484-497.
  27. Kynning, M.K., E. Westerberg, L. Forsell, M. Creignou, D.M. Berggren, B. Tesi, E. Bernard, E. Papaemmanuil, Y. Nannya, L.C. Franco, D. Valentini, E.H. Lindberg, S. Ogawa, E. Ejerblad, and J. Ungerstedt, Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study. Br J Haematol, 2025.
  28. Makiyama, J., N. Ohno, K. Jimbo, T. Kawamata, K. Yokoyama, T. Konuma, S. Kato, T. Takemura, A. Ito, T. Tanaka, Y. Inamoto, S. Fuji, Y. Imai, S. Takahashi, Y. Nannya, A. Tojo, T. Fukuda, and K. Uchimaru, Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in Tokyo. Int J Hematol, 2025.
  29. Matsumoto, Y., D. Kato, A. Muramatsu, M. Sugitani, T. Kobayashi, T. Iwai, M. Mori, D. Motooka, J. Nakata, S. Ogawa, Y. Nannya, and H. Uchiyama, Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations. Int J Hematol, 2025.
  30. Mitsuyuki, S., Y. Shimomura, H. Mizumaki, M. Yanada, S. Mizuno, N. Uchida, N. Doki, A. Ito, M. Tanaka, T. Nishida, Y. Katayama, S. Yoshihara, T. Eto, S. Takada, S. Ota, M. Toyosaki, Y. Hasegawa, H. Nakamae, K. Kawamura, M. Onizuka, T. Fukuda, M. Ohbiki, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERG. Leukemia, 2025. 39(2): p. 495-498.
  31. Mori, M., T. Sakai, T. Oka, M. Sakurada, M. Iwasaki, J. Takeda, J. Kanda, Y. Nannya, S. Ogawa, A. Takaori-Kondo, K. Moriyoshi, and H. Kawabata, Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow. Br J Haematol, 2025.
  32. Murao, T., T. Inaba, Y. Yamane, M. Kiyota, K. Wada, Y. Nannya, and E. Kawata, IKZF1 and KRAS Mutated B-Cell Acute Lymphoblastic Leukemia with Pseudo-Chediak-Higashi Granules. Intern Med, 2025.
  33. Nakamura, F., K. Sasaki, Y. Nannya, H. Iso, Y. Nakamura, Y. Imai, S. Ogawa, and K. Mitani, A CML Patient Carrying BCR::ABL1 Splicing Variants Did Not Experience Blast Crisis for 15 Years without Responding to Various TKIs. Intern Med, 2025. 64(3): p. 455-458.
  34. Nakashima, M., K. Nagai, N. Takao, N. Araya, Y. Kuze, J. Mizuike, S. Tosaka, S. Aratani, N. Yagishita, E. Horibe, T. Watanabe, T. Sato, Y. Nannya, Y. Suzuki, K. Uchimaru, M. Yamagishi, and Y. Yamano, Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic intervention. Nat Commun, 2025. 16(1): p. 9874.
  35. Oda, Y., S. Kato, M. Monna-Oiwa, S. Andoh, Y. Nannya, S. Takahashi, and T. Konuma, G-CSF-combined conditioning in allogeneic transplantation for non-remission acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Blood Cell Ther, 2025. 8(1): p. 181-185.
  36. Oka, T., T. Nakajima, M. Iwasaki, J. Takeda, M. Torishima, M. Sakurada, T. Shimizu, T. Shindo, M. Fujimoto, S. Otsuki, H. Haga, K. Sugano, M. Ando, C. Mizumoto, J. Kanda, Y. Nannya, S. Ogawa, A. Takaori-Kondo, and S. Kosugi, The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short Report. EJHaem, 2025. 6(4): p. e70116.
  37. Ooi, J., S. Kato, and T. Konuma, Cord blood freezing bag breakage at transplant centres: Low breakage rate in Japan. Vox Sang, 2025. 120(7): p. 746-747.
  38. Oshima, M., N. Takayama, Y. Nakajima-Takagi, D. Shinoda, N. Itokawa, S. Kurosawa, S. Kaito, T. Kamiya, Y. Yamada, S. Andoh, K. Kayamori, S.K. Paul, M.A. Kanashiro, T. Muto, S. Tsukamoto, E. Sakaida, E. Sato, N. Yusa, K. Yokoyama, Y. Nannya, S. Imoto, B. Rahmutulla, A. Kaneda, K. Yamaguchi, Y. Furukawa, N. Doki, K. Eto, K. Nishikawa, Y. Ding, T. Myojo, Y. Harada, H. Harada, and A. Iwama, Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome. Nat Commun, 2025. 16(1): p. 10726.
  39. Oshima, S., J. Kanda, J. Takeda, T. Sakamoto, C. Mizumoto, K. Yamashita, Y. Nannya, S. Ogawa, and A. Takaori-Kondo, Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib. Ann Hematol, 2025. 104(6): p. 3517-3522.
  40. Shimomura, Y., T. Kitamura, M. Yanada, S. Mizuno, T. Kondo, S. Yoshihara, M. Tanaka, K. Inai, Y. Katayama, M. Onizuka, T. Fukuda, H. Nakamae, M. Kurokawa, S. Yano, M. Nara, M. Masuko, S. Miyakoshi, T. Eto, M. Yoshimitsu, F. Ishimaru, J. Kanda, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission. Cytotherapy, 2025. 27(3): p. 316-323.
  41. Shoji, K., K. Yoshida, S. Iyoda, M. Ishikawa, M. Tanaka, M. Nobe, N. Saito, Y. Shino, Y. Nannya, G. Yamato, S. Tsujimoto, N. Shiba, Y. Hayashi, Y. Shiozawa, Y. Shiraishi, K. Chiba, A. Okada, H. Tanaka, S. Miyano, Y. Koga, H. Goto, K. Terui, E. Ito, N. Kiyokawa, D. Tomizawa, T. Taga, H. Moritake, A. Tawa, J. Takita, M. Nishikori, S. Adachi, S. Ogawa, and H. Matsuo, Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia. Haematologica, 2025.
  42. Suzuki, K., S. Kusayanagi, Y. Kuze, M. Hata, S. Kozuma, K. Jimbo, Y. Nannya, Y. Suzuki, K. Uchimaru, and M. Yamagishi, Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-beta axis in adult T-cell leukemia/lymphoma. Leukemia, 2025. 39(10): p. 2465-2476.
  43. Takamori, H., Y.J. Huang, H. Fukushima, K. Yokoyama, T.Y. Huang, M.C. Kuo, S. Ogawa, Y. Nannya, and L.Y. Shih, Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation. Leukemia, 2025.
  44. Terakawa, T., S. Fuji, H. Shi, Y. Amemiya, W. Nakahara, Y. Matsuoka, Y. Tada, Y. Shingai, S. Yuda, J. Ishikawa, H. Satomi, H. Murakami, M. Suga, N. Hosen, Y. Nannya, S. Ogawa, and T. Yokota, Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy. Haematologica, 2025.
  45. Teramoto, M., Y. Shimomura, H. Hosoi, M. Yanada, S. Mizuno, N. Uchida, Y. Mori, N. Doki, W. Takeda, Y. Katayama, S. Ota, H. Nakamae, T. Kuriyama, S. Yoshihara, M. Toyosaki, K. Imada, M. Sakata-Yanagimoto, M. Onizuka, J. Kanda, T. Fukuda, Y. Atsuta, and T. Konuma, Survival outcomes and risk factors of second allogeneic hematopoietic cell transplantation in non-remission status for acute myeloid leukemia. Bone Marrow Transplant, 2025. 60(9): p. 1275-1277.
  46. Watanabe, K., M. Ogawa, A. Shinozaki-Ushiku, S. Tsutsumi, K. Tatsuno, H. Aburatani, H. Kage, and K. Oda, Real-World Data Analysis of Genomic Alterations Detected by a Dual DNA-RNA Comprehensive Genomic Profiling Test. Cancer Sci, 2025. 116(7): p. 1984-1995.
  47. Xi, Q., A. Kunita, M. Ogawa, M. Ka, S. Tanimoto, S. Tsuchimochi, S. Nagai, A. Matsunaga, T. Fukuda, K. Watanabe, K. Sone, A. Shinozaki-Ushiku, K. Kawana, T. Ushiku, Y. Osuga, K. Katayama, H. Kage, and K. Oda, Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1 inhibition. Oncogene, 2025. 44(19): p. 1375-1386.
  48. Xi, Q., A. Kunita, M. Ogawa, M. Kawakami, M. Ka, S. Nagai, A.Q. Duong, A. Taguchi, K. Watanabe, T. Fukuda, K. Sone, A. Shinozaki-Ushiku, T. Ushiku, Y. Hirota, H. Kage, K. Katayama, and K. Oda, PLK1 or WEE1 inhibition targets homologous recombination repair proficiency in BRCA1/2 wild-type high-grade serous ovarian cancer. Cell Death Dis, 2025. 16(1): p. 905.
  49. Yamasaki, S., M. Yanada, H. Araie, T. Fukuda, Y. Kanda, H. Tashiro, N. Uchida, K. Ozeki, S. Ota, Y. Onishi, N. Doki, T. Oyake, S. Takada, M. Sakurai, Y. Kondo, H. Nakamae, T. Kawakita, M. Onizuka, Y. Atsuta, and T. Konuma, Comparative analysis of allogeneic hematopoietic cell transplantation in patients with therapy-related and de novo acute promyelocytic leukemia A retrospective study. Sci Rep, 2025. 15(1): p. 10967.
  50. Yanada, M., S. Yamasaki, H. Hosoi, S. Mizuno, K. Harada, N. Doki, S.I. Fujiwara, N. Hiramoto, Y. Hasegawa, K. Ishiwata, T. Nishida, N. Asada, T. Suzuki, M. Sakata-Yanagimoto, N. Uchida, J. Kanda, M. Yoshimitsu, Y. Kanda, T. Fukuda, M. Ohbiki, Y. Atsuta, and T. Konuma, Association of FLT3-ITD and NPM1 mutations with outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Bone Marrow Transplant, 2025. 60(6): p. 894-896.
  51. Yanada, M., S. Yamasaki, S. Mizuno, J. Sugita, T. Fujino, Y. Misaki, M. Tanaka, N. Uchida, M. Onizuka, N. Doki, S. Ota, M. Sawa, T. Kawakita, Y. Hasegawa, H. Nakamae, K. Ishiwata, N. Hiramoto, F. Ishimaru, J. Kanda, M. Ohbiki, Y. Atsuta, H. Nakasone, and T. Konuma, Comparison of single-unit umbilical cord blood transplantation and haploidentical transplantation using posttransplant cyclophosphamide during first complete remission of acute myeloid leukemia. Bone Marrow Transplant, 2025.
  52. Yokoyama, A., K. Watanabe, Y. Inoue, T. Hirano, M. Tamaoki, K. Hirohashi, S. Kawaguchi, Y. Ishida, Y. Takeuchi, Y. Kishimoto, S.K. Kim, C. Katada, Y. Nannya, H. Seno, S. Ogawa, M. Muto, and N. Kakiuchi, Somatic mosaicism in the buccal mucosa reflects lifestyle and germline risk factors for esophageal squamous cell carcinoma. Sci Transl Med, 2025. 17(796): p. eadq6740.
  53. Yokoyama, K., N. Yokoyama, A. Shinozaki-Ushiku, M. Ito, H. Takamori, S. Takahashi, E. Shimizu, S. Imoto, T. Todo, and Y. Nannya, Multihit Somatic Mosaicism of TP53 Pathogenic Variants in a Patient Mimicking Li-Fraumeni Syndrome. JCO Precis Oncol, 2025. 9: p. e2500392.
  54. Zaimoku, Y., T. Imi, T. Hatada, H. Mizumaki, H. Mura, H. Yoshino, Y. Kano, M. Kobayashi, E. Morishita, N. Fushida, T. Matsushita, K. Mizuguchi, H. Ikeda, Y. Nannya, S. Ogawa, K. Hosomichi, N. Doki, Y. Katayama, T. Koike, K.I. Matsuoka, T. Nishida, Y. Takahashi, K. Kataoka, H. Nakazawa, Y. Ueda, T. Fukuda, T. Ichinohe, F. Ishimaru, M. Onizuka, Y. Atsuta, T. Miyamoto, T. Japanese Society of, and T. Cellular, Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure. Clin Exp Med, 2025. 25(1): p. 300.

Back to top ↑

Publications

2024

  1. Bernard, E., R.P. Hasserjian, P.L. Greenberg, J.E. Arango Ossa, M. Creignou, H. Tuechler, J. Gutierrez-Abril, D. Domenico, J.S. Medina-Martinez, M. Levine, K. Liosis, N. Farnoud, M. Sirenko, M. Jadersten, U. Germing, G. Sanz, A.A. van de Loosdrecht, Y. Nannya, O. Kosmider, M.Y. Follo, F. Thol, L. Zamora, R.F. Pinheiro, A. Pellagatti, H.K. Elias, D. Haase, C. Ganster, L. Ades, M. Tobiasson, L. Palomo, M.G. Della Porta, P. Fenaux, M. Belickova, M.R. Savona, V.M. Klimek, F.P.S. Santos, J. Boultwood, I. Kotsianidis, V. Santini, F. Sole, U. Platzbecker, M. Heuser, P. Valent, C. Finelli, M.T. Voso, L.Y. Shih, M. Fontenay, J.H. Jansen, J. Cervera, N. Gattermann, B.L. Ebert, R. Bejar, L. Malcovati, S. Ogawa, M. Cazzola, E. Hellstrom-Lindberg, and E. Papaemmanuil, Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood, 2024. 144(15): p. 1617-1632.
  2. Boddu, P.C., A.K. Gupta, R. Roy, B. De La Pena Avalos, A. Olazabal-Herrero, N. Neuenkirchen, J.T. Zimmer, N.S. Chandhok, D. King, Y. Nannya, S. Ogawa, H. Lin, M.D. Simon, E. Dray, G.M. Kupfer, A. Verma, K.M. Neugebauer, and M.M. Pillai, Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape. Mol Cell, 2024. 84(8): p. 1475-1495 e18.
  3. Elbadry, M.I., A. Tawfeek, T. Hirano, M.A. El-Mokhtar, M. Kenawey, A.M. Helmy, S. Ogawa, M.Z. Mughal, and Y. Nannya, A rare homozygous variant in TERT gene causing variable bone marrow failure, fragility fractures, rib anomalies and extremely short telomere lengths with high serum IgE. Br J Haematol, 2024. 204(3): p. 1086-1095.
  4. Fukushi, K., M. Monna-Oiwa, S. Kato, M. Isobe, S. Kuroda, Y. Nannya, S. Takahashi, and T. Konuma, Influence of interruption of oral mycophenolate mofetil for graft-versus-host disease prophylaxis on outcomes after single cord blood transplantation. Blood Cell Ther, 2024. 7(2): p. 41-48.
  5. Imahashi, N., N. Kurita, T. Konuma, S. Takahashi, T. Nishida, M. Tanaka, H. Nakamae, T. Kawakita, S. Ota, N. Doki, Y. Onishi, M. Sawa, K. Ozeki, N. Hiramoto, M. Onizuka, F. Ishimaru, T. Ichinohe, Y. Atsuta, and J. Kanda, Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens. Transplant Cell Ther, 2024. 30(3): p. 318 e1-318 e11.
  6. Isobe, M., S. Kato, M. Suzuki, Y. Nannya, S. Takahashi, and T. Konuma, Disseminated Fusarium keratoplasticum Infection with Myocardial Involvement in an Adult Cord Blood Transplant Recipient. Mycopathologia, 2024. 189(6): p. 95.
  7. Iyoda, S., K. Yoshida, K. Shoji, N. Ito, M. Tanaka, Y. Nannya, G. Yamato, S. Tsujimoto, N. Shiba, Y. Hayashi, Y. Shiozawa, Y. Shiraishi, K. Chiba, A. Okada, H. Tanaka, S. Miyano, Y. Koga, H. Goto, H. Moritake, K. Terui, E. Ito, N. Kiyokawa, D. Tomizawa, T. Taga, A. Tawa, J. Takita, M. Nishikori, S. Adachi, S. Ogawa, and H. Matsuo, KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia. Leukemia, 2024. 38(7): p. 1609-1612.
  8. Jimbo, K., T. Kawamata, Y. Inamoto, A. Ito, K. Yokoyama, A. Sato, T. Fukuda, K. Uchimaru, and Y. Nannya, Flow cytometric profiles with CD7 and CADM1 in CD4+ T cells are promising indicators for prognosis of aggressive ATL. Blood Adv, 2024. 8(14): p. 3760-3770.
  9. Kaito, S., K. Aoyama, M. Oshima, A. Tsuchiya, M. Miyota, M. Yamashita, S. Koide, Y. Nakajima-Takagi, H. Kozuka-Hata, M. Oyama, T. Yogo, T. Yabushita, R. Ito, M. Ueno, A. Hirao, K. Tohyama, C. Li, K.C. Kawabata, K. Yamaguchi, Y. Furukawa, H. Kosako, A. Yoshimi, S. Goyama, Y. Nannya, S. Ogawa, K. Agger, K. Helin, S. Yamazaki, H. Koseki, N. Doki, Y. Harada, H. Harada, A. Nishiyama, M. Nakanishi, and A. Iwama, Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization. Nat Commun, 2024. 15(1): p. 7359.
  10. Kaito, Y., E. Sugimoto, F. Nakamura, Y. Tsukune, M. Sasaki, S. Yui, H. Yamaguchi, S. Goyama, Y. Nannya, K. Mitani, H. Tamura, and Y. Imai, Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. Haematologica, 2024. 109(4): p. 1107-1120.
  11. Kamoi, K., K. Uchimaru, Y. Nannya, A. Tojo, T. Watanabe, and K. Ohno-Matsui, Sexual transmission of HTLV-1 resulting in uveitis with short-term latency and low proviral load. J Med Virol, 2024. 96(10): p. e70000.
  12. Kawamura, S., M. Tamaki, T. Konuma, M. Onizuka, E. Sakaida, H. Hayashi, N. Doki, T. Nishida, M. Sawa, H. Ohigashi, T. Fukuda, J. Ishikawa, K.I. Matsuoka, T. Kawakita, M. Tanaka, F. Ishimaru, T. Ichinohe, Y. Atsuta, Y. Kanda, K. Yakushijin, J. Kanda, and H. Nakasone, Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT. Cytotherapy, 2024. 26(11): p. 1353-1361.
  13. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, S. Andoh, K. Yokoyama, Y. Nannya, and S. Takahashi, Recipient IL-17A polymorphism rs2275913 is associated with acute graft-versus-host disease after single-unit cord blood transplantation. Transpl Immunol, 2024. 86: p. 102096.
  14. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, M. Isobe, K. Yokoyama, Y. Nannya, and S. Takahashi, Higher relapse and worse overall survival in recipients with CTLA-4 AA genotype of rs231775 following single-unit cord blood transplantation in adults. Leuk Lymphoma, 2024: p. 1-11.
  15. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, M. Isobe, K. Yokoyama, Y. Nannya, and S. Takahashi, Donor NKG2D rs1049174 polymorphism predicts hematopoietic recovery and event-free survival after single-unit cord blood transplantation in adults. Bone Marrow Transplant, 2024. 59(4): p. 566-568.
  16. Konuma, T., M. Hamatani-Asakura, M. Monna-Oiwa, S. Kato, M. Isobe, K. Yokoyama, S. Takahashi, and Y. Nannya, Effect of IL-2 polymorphism rs2069762 on single-unit cord blood transplant outcomes. Cytokine, 2024. 179: p. 156636.
  17. Konuma, T., M. Hamatani-Asakura, E. Nagai, E. Adachi, S. Kato, M. Isobe, M. Monna-Oiwa, S. Takahashi, H. Yotsuyanagi, and Y. Nannya, Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients. Int J Hematol, 2024. 120(2): p. 229-240.
  18. Konuma, T., K. Harada, A. Shinohara, N. Uchida, N. Shingai, A. Ito, Y. Ozawa, M. Tanaka, M. Sawa, M. Onizuka, Y. Katayama, N. Hiramoto, N. Nakano, T. Kimura, Y. Kanda, T. Fukuda, Y. Atsuta, H. Nakasone, and J. Kanda, Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy. Am J Hematol, 2024. 99(2): p. 263-273.
  19. Konuma, T., H. Itonaga, Y. Shimomura, M. Fujioka, K. Aoki, N. Uchida, M. Onizuka, A. Jinguji, M. Tanaka, Y. Ueda, Y. Katayama, M. Sawa, H. Tanaka, H. Nakamae, T. Kawakita, Y. Maruyama, S. Takahashi, F. Ishimaru, J. Kanda, T. Ichinohe, and Y. Atsuta, Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy. Hematol Oncol, 2024. 42(1): p. e3217.
  20. Konuma, T., K. Miyao, H. Nakasone, F. Ouchi, T. Fukuda, M. Tanaka, Y. Ozawa, S. Ota, T. Kawakita, N. Uchida, M. Sawa, Y. Katayama, N. Hiramoto, T. Eto, T. Ichinohe, Y. Atsuta, J. Kanda, T. Donor/Source Working Group of the Japanese Society for, and T. Cellular, Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy, 2024. 26(8): p. 910-920.
  21. Konuma, T., M. Monna-Oiwa, S. Kato, S. Andoh, M. Isobe, Y. Nannya, and S. Takahashi, Levels of C-Reactive Protein and Body Temperature Elevation During Neutropenia Predict Engraftment and Non-Relapse Mortality for Unrelated Single-Unit Cord Blood Transplantation in Adults. Transplant Cell Ther, 2024. 30(11): p. 1104 e1-1104 e14.
  22. Konuma, T., M. Monna-Oiwa, S. Kato, M. Isobe, Y. Nannya, and S. Takahashi, Feasibility and safety of the discontinuation of systemic immunosuppressive treatment after single-unit cord blood transplantation in adults. Bone Marrow Transplant, 2024. 59(8): p. 1127-1136.
  23. Konuma, T., M. Monna-Oiwa, S. Kato, M. Isobe, S. Takahashi, and Y. Nannya, Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults. Acta Haematol, 2024: p. 1-11.
  24. Konuma, T., N. Uchida, W. Takeda, N. Doki, S. Yoshihara, T. Nishida, T. Kuriyama, M. Tanaka, H. Ohigashi, H. Nakamae, Y. Katayama, S. Ota, Y. Hashii, F. Ishimaru, T. Fukuda, M. Ohbiki, and Y. Atsuta, RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based study. Vox Sang, 2024. 119(6): p. 612-618.
  25. Konuma, T., S. Yamasaki, K. Ishiyama, S. Mizuno, H. Hayashi, N. Uchida, M. Shimabukuro, M. Tanaka, T. Kuriyama, M. Onizuka, K. Ishiwata, M. Sawa, T. Tanaka, H. Ohigashi, S.I. Fujiwara, K.I. Matsuoka, S. Ota, T. Nishida, Y. Kanda, T. Fukuda, Y. Atsuta, H. Nakasone, M. Yanada, L. Adult Acute Myeloid, T. Donor/source Working Groups of the Japanese Society for, and T. Cellular, Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status. Transplant Cell Ther, 2024. 30(2): p. 215 e1-215 e18.
  26. Kubota, H., H. Ueno, K. Tasaka, T. Isobe, S. Saida, I. Kato, K. Umeda, M. Hiwatari, D. Hasegawa, T. Imamura, N. Kakiuchi, Y. Nannya, S. Ogawa, H. Hiramatsu, and J. Takita, RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Adv, 2024. 8(5): p. 1258-1271.
  27. Kubota, Y., M. Sakurai, Y. Nannya, Y. Kogure, K. Shiroshita, S. Fujita, K. Yamaguchi, K. Mizuno, J. Kato, T. Mori, S. Ogawa, and K. Kataoka, Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood. Ann Hematol, 2024.
  28. Kuwatsuka, Y., H. Ito, K. Tabuchi, T. Konuma, N. Uchida, Y. Inamoto, K. Inai, T. Nishida, K. Ikegame, T. Eto, Y. Katayama, K. Kataoka, M. Tanaka, S. Takahashi, T. Fukuda, T. Ichinohe, F. Kimura, J. Kanda, Y. Atsuta, and K. Matsuo, Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data. Bone Marrow Transplant, 2024. 59(9): p. 1295-1301.
  29. Kuwatsuka, Y., R. Kasajima, R. Yamaguchi, N. Uchida, T. Konuma, M. Tanaka, N. Shingai, S. Miyakoshi, Y. Kozai, Y. Uehara, T. Eto, M. Toyosaki, T. Nishida, F. Ishimaru, K. Kato, T. Fukuda, S. Imoto, Y. Atsuta, and S. Takahashi, Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplant Cell Ther, 2024. 30(4): p. 444 e1-444 e11.
  30. Matsubara, Y., H. Kiyohara, Y. Mikami, K. Nanki, H. Namkoong, S. Chubachi, H. Tanaka, S. Azekawa, S. Sugimoto, Y. Yoshimatsu, T. Sujino, K. Takabayashi, N. Hosoe, T. Sato, M. Ishii, N. Hasegawa, Y. Okada, R. Koike, Y. Kitagawa, A. Kimura, S. Imoto, S. Miyano, S. Ogawa, K. Fukunaga, T. Kanai, and C.-T.F. Japan, Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study. J Gastroenterol, 2024. 59(3): p. 195-208.
  31. Matsubara, Y., Y. Ota, T. Denda, Y. Tanaka, M. Isobe, S. Kato, T. Konuma, S. Takahashi, Y. Hirata, H. Ikematsu, K. Baba, and N. Boku, Both Th1 and Th2 CD4 + T-Cell Lineage Infiltrations Decrease in Post-hematopoietic Stem Cell Transplantation Colon Adenoma. J Gastrointest Cancer, 2024. 55(4): p. 1551-1558.
  32. Mitsuyuki, S., Y. Shimomura, H. Mizumaki, M. Yanada, S. Mizuno, N. Uchida, N. Doki, A. Ito, M. Tanaka, T. Nishida, Y. Katayama, S. Yoshihara, T. Eto, S. Takada, S. Ota, M. Toyosaki, Y. Hasegawa, H. Nakamae, K. Kawamura, M. Onizuka, T. Fukuda, M. Ohbiki, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERG. Leukemia, 2024.
  33. Miyashita, E., N. Sugihara, M. Tanaka, H. Iwasaki, M. Monna-Oiwa, M. Isobe, S. Kato, S. Takahashi, Y. Nannya, Y. Tsuru, and T. Konuma, Prevalence and factors of polypharmacy among disease-free survivors of adults after allogeneic hematopoietic cell transplantation. Leuk Lymphoma, 2024. 65(4): p. 516-520.
  34. Mizuike, J., K. Suzuki, S. Tosaka, Y. Kuze, S. Kobayashi, M. Nakashima, K. Jimbo, Y. Nannya, Y. Suzuki, K. Uchimaru, and M. Yamagishi, Rewired chromatin structure and epigenetic gene dysregulation during HTLV-1 infection to leukemogenesis. Cancer Sci, 2024.
  35. Mizuno, S., H. Hosoi, A. Takami, T. Kawata, N. Doki, W. Takeda, M. Tanaka, T. Nishida, N. Uchida, Y. Hasegawa, M. Sawa, S. Ota, M. Onizuka, H. Nakamae, N. Asada, T. Fukuda, M. Yoshimitsu, Y. Kanda, M. Ohbiki, Y. Atsuta, T. Konuma, and M. Yanada, Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Ann Hematol, 2024. 103(12): p. 5903-5913.
  36. Moriguchi, M., H. Nakamae, M. Nishimoto, J. Sugita, M. Yanada, T. Toubai, Y. Hasegawa, M. Hino, T. Nishida, N. Kurita, M. Sawa, T. Fukuda, A. Jinguji, S. Ota, K.I. Matsuoka, T. Eto, N. Hiramoto, T. Ando, K. Kawamura, Y. Kanda, Y. Atsuta, M. Ohbiki, H. Nakasone, and T. Konuma, Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia. Br J Haematol, 2024. 205(6): p. 2376-2386.
  37. Murakami, K., S.I. Tago, S. Takishita, H. Morikawa, R. Kojima, K. Yokoyama, M. Ogawa, H. Fukushima, H. Takamori, Y. Nannya, S. Imoto, and M. Fuji, Pathogenicity Prediction of Gene Fusion in Structural Variations: A Knowledge Graph-Infused Explainable Artificial Intelligence (XAI) Framework. Cancers (Basel), 2024. 16(10).
  38. Nakamura, M., K. Chonabayashi, M. Narita, Y. Matsumura, M. Nishikawa, Y. Ochi, Y. Nannya, M. Hishizawa, D. Inoue, R. Delwel, S. Ogawa, A. Takaori-Kondo, and Y. Yoshida, Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs. Br J Haematol, 2024. 205(4): p. 1430-1443.
  39. Nakamura, N., N. Yamamoto, T. Kondo, M. Matsumoto, R. Ikunari, T. Sakai, Y. Tanaka, H. Tsunemine, J. Takeda, J. Kanda, Y. Nannya, S. Ogawa, A. Takaori-Kondo, and N. Arima, Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome. Int J Hematol, 2024. 119(6): p. 762-767.
  40. Nakaya, Y., H. Koh, T. Konuma, Y. Shimomura, K. Ishiyama, H. Itonaga, M. Hino, N. Doki, T. Nishida, H. Ohigashi, K.I. Matsuoka, Y. Kanda, Y. Maruyama, M. Sawa, T. Eto, N. Hiramoto, T. Fukuda, Y. Atsuta, and H. Nakamae, HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome. Transplant Cell Ther, 2024. 30(3): p. 316 e1-316 e12.
  41. Nannya, Y., Addressing Information Gaps and Revising Coverage Terms and Conditions for Cancer Panel Testing. JMA J, 2024. 7(2): p. 267-268.
  42. Niiyama-Uchibori, Y., S. Mizutani, T. Tsukamoto, H. Okamoto, D. Ide, A. Onishi, D. Kato, T. Fujino, Y. Shimira, A. Miyagawa-Hayashino, E. Konishi, K. Karube, Y. Nannya, and J. Kuroda, Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63. EJHaem, 2024. 5(4): p. 798-801.
  43. Ogawa, S., T. Sakamoto, R. Matsuoka, K. Ishitsuka, Y. Ogino, A. Sootome, K. Makishima, C. Yoshida, Y. Ito, S. Shimizu, T. Suyama, A. Shinagawa, T. Ito, N. Obara, M. Kusakabe, M. Sakata-Yanagimoto, Y. Miyazaki, Y. Nannya, and S. Chiba, Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine. Cancer Rep (Hoboken), 2024. 7(1): p. e1938.
  44. Okuda, R., Y. Ochi, R. Saiki, T. Yamanaka, C. Terao, T. Yoshizato, M.M. Nakagawa, L. Zhao, K. Ohyashiki, N. Hiramoto, M. Sanada, H. Handa, S. Kasahara, Y. Miyazaki, N. Sezaki, L.Y. Shih, W. Kern, N. Kanemura, T. Kitano, S. Imashuku, M. Watanabe, M. Creignou, K. Chonabayashi, K. Usuki, T. Ishikawa, A. Gotoh, Y. Atsuta, Y. Shiraishi, K. Mitani, S. Chiba, A. Takaori-Kondo, S. Miyano, Y. Kamatani, T. Haferlach, E. Hellstrom-Lindberg, K. Matsuda, Y. Yoshida, H. Makishima, Y. Nannya, and S. Ogawa, Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10). Leukemia, 2024.
  45. Oliva, E.N., M. Cuzzola, M.D. Porta, A. Candoni, P. Salutari, G.A. Palumbo, G. Reda, G. Ianni, M. Zampini, S. D'Amico, G. Tripepi, D. Capelli, C. Alati, M.C. Cannata, P. Niscola, B. Serio, S. Barilla, P. Musto, E. Vigna, L.M.A. Melillo, R. Tripepi, M.E. Zannier, Y. Nannya, S. Ogawa, and C. Mammi, Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2). Int J Mol Sci, 2024. 25(21).
  46. Ono, R., K. Sakamoto, K. Kudo, A. Sato, K. Kudo, H. Fujino, Y. Kawahara, H. Hashimoto, T. Doi, R. Yanagisawa, T. Kawamata, O. Miyazaki, A. Nakazawa, Y. Ota, H. Kanegane, Y. Nakazawa, K. Horibe, A.M. Saito, A. Manabe, K. Usuki, H. Kiyoi, A. Morimoto, A. Tojo, and Y. Shioda, Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan. BMJ Open, 2024. 14(6): p. e084159.
  47. Sato, A., N. Yusa, H. Takamori, E. Shimizu, K. Yokoyama, S. Ichikawa, H. Yokoyama, Y. Kasahara, K. Enda, F. Fujishima, R. Ichinohasama, Y. Ota, S. Imoto, and Y. Nannya, Common progenitor origin for Rosai-Dorfman disease and clear cell sarcoma. J Pathol, 2024. 264(3): p. 243-249.
  48. Shimomura, Y., T. Kitamura, T. Konuma, Y. Nakaya, N. Doki, M. Sawa, H. Nakamae, T. Eto, T. Nishida, H. Ohigashi, S. Ota, M. Onizuka, N. Hiramoto, T. Kawakita, J. Kanda, T. Ichinohe, Y. Atsuta, and H. Itonaga, Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndrome. Am J Hematol, 2024. 99(2): p. E42-E45.
  49. Shimomura, Y., T. Kitamura, M. Yanada, S. Mizuno, T. Kondo, S. Yoshihara, M. Tanaka, K. Inai, Y. Katayama, M. Onizuka, T. Fukuda, H. Nakamae, M. Kurokawa, S. Yano, M. Nara, M. Masuko, S. Miyakoshi, T. Eto, M. Yoshimitsu, F. Ishimaru, J. Kanda, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission. Cytotherapy, 2024.
  50. Shiozawa, Y., S. Fujita, Y. Nannya, S. Ogawa, N. Nomura, T. Kiguchi, N. Sezaki, H. Kudo, and T. Toyama, First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants. Int J Hematol, 2024. 119(4): p. 465-471.
  51. Sugita, J., K. Morita, T. Konuma, and M. Yanada, Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia. Ann Hematol, 2024. 103(12): p. 4851-4868.
  52. Sugiura, H., T. Ishikawa, T. Kuroi, S. Okamoto, N. Nomura, T. Masunari, N. Sezaki, S. Ogawa, Y. Nannya, and M. Makita, Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples. Int J Hematol, 2024. 120(5): p. 594-600.
  53. Suzuki, Y., T. Kitawaki, Y. Arai, S. Nakagawa, K. Chonabayashi, Y. Nannya, K. Yamashita, S. Ogawa, and A. Takaori-Kondo, [Concentration of gilteritinib in the cerebrospinal fluid of a patient with relapsed FLT3-ITD positive acute myeloid leukemia with optic nerve involvement]. Rinsho Ketsueki, 2024. 65(8): p. 727-731.
  54. Takano, K., M. Monna-Oiwa, M. Isobe, S. Kato, S. Takahashi, Y. Nannya, and T. Konuma, Low urinary sodium-to-potassium ratio in the early phase following single-unit cord blood transplantation is a predictive factor for poor non-relapse mortality in adults. Sci Rep, 2024. 14(1): p. 1413.
  55. Tomofuji, Y., R. Edahiro, K. Sonehara, Y. Shirai, K.H. Kock, Q.S. Wang, S. Namba, J. Moody, Y. Ando, A. Suzuki, T. Yata, K. Ogawa, T. Naito, H. Namkoong, Q.X. Xuan Lin, E.V. Buyamin, L.M. Tan, R. Sonthalia, K.Y. Han, H. Tanaka, H. Lee, N. Asian Immune Diversity Atlas, C.-T.F. Japan, P. Biobank Japan, T. Okuno, B. Liu, K. Matsuda, K. Fukunaga, H. Mochizuki, W.Y. Park, K. Yamamoto, C.C. Hon, J.W. Shin, S. Prabhakar, A. Kumanogoh, and Y. Okada, Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues. Cell Genom, 2024. 4(8): p. 100625.
  56. Tsuru, Y., N. Sugihara, H. Iwasaki, M. Monna-Oiwa, S. Kato, Y. Nannya, S. Takahashi, and T. Konuma, Sun protection behaviors among adult survivors receiving hematopoietic cell transplantation: a cross-sectional survey of a single institution in Japan. Leuk Lymphoma, 2024. 65(13): p. 2031-2034.
  57. Wang, Q.S., T. Hasegawa, H. Namkoong, R. Saiki, R. Edahiro, K. Sonehara, H. Tanaka, S. Azekawa, S. Chubachi, Y. Takahashi, S. Sakaue, S. Namba, K. Yamamoto, Y. Shiraishi, K. Chiba, H. Tanaka, H. Makishima, Y. Nannya, Z. Zhang, R. Tsujikawa, R. Koike, T. Takano, M. Ishii, A. Kimura, F. Inoue, T. Kanai, K. Fukunaga, S. Ogawa, S. Imoto, S. Miyano, Y. Okada, and C.-T.F. Japan, Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance. Nat Genet, 2024. 56(10): p. 2054-2067.
  58. Wang, Q.S., T. Hasegawa, H. Namkoong, R. Saiki, R. Edahiro, K. Sonehara, H. Tanaka, S. Azekawa, S. Chubachi, Y. Takahashi, S. Sakaue, S. Namba, K. Yamamoto, Y. Shiraishi, K. Chiba, H. Tanaka, H. Makishima, Y. Nannya, Z. Zhang, R. Tsujikawa, R. Koike, T. Takano, M. Ishii, A. Kimura, F. Inoue, T. Kanai, K. Fukunaga, S. Ogawa, S. Imoto, S. Miyano, Y. Okada, and C.-T.F. Japan, Publisher Correction: Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance. Nat Genet, 2024. 56(10): p. 2281.
  59. Watanabe, M., T. Konuma, N. Imahashi, S. Terakura, S. Seo, S. Morishima, N. Uchida, N. Doki, M. Tanaka, T. Nishida, T. Kawakita, T. Eto, S. Takahashi, M. Sawa, Y. Uehara, S.W. Kim, F. Ishimaru, T. Ichinohe, T. Fukuda, Y. Atsuta, and J. Kanda, Scoring system for optimal cord blood unit selection for single cord blood transplantation. Cytotherapy, 2024. 26(3): p. 286-298.
  60. Yamagishi, M., Y. Kuze, S. Kobayashi, M. Nakashima, S. Morishima, T. Kawamata, J. Makiyama, K. Suzuki, M. Seki, K. Abe, K. Imamura, E. Watanabe, K. Tsuchiya, I. Yasumatsu, G. Takayama, Y. Hizukuri, K. Ito, Y. Taira, Y. Nannya, A. Tojo, T. Watanabe, S. Tsutsumi, Y. Suzuki, and K. Uchimaru, Mechanisms of action and resistance in histone methylation-targeted therapy. Nature, 2024. 627(8002): p. 221-228.
  61. Yanada, M., S. Yamasaki, T. Kondo, T. Kawata, K. Harada, N. Uchida, N. Doki, S. Yoshihara, Y. Katayama, T. Eto, M. Tanaka, S. Takada, T. Kawakita, T. Nishida, S. Ota, K. Serizawa, M. Onizuka, Y. Kanda, T. Fukuda, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia, 2024. 38(3): p. 513-520.
  62. Yanada, M., S. Yano, Y. Kuwatsuka, K. Kawamura, T. Fukuda, T. Ichinohe, Y. Hashii, H. Goto, K. Kato, F. Ishimaru, A. Sato, M. Onizuka, K. Matsuo, Y. Ito, A. Yanagisawa, M. Ohbiki, K. Tabuchi, Y. Atsuta, J. Kanda, and T. Konuma, The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. Bone Marrow Transplant, 2024. 59(4): p. 541-549.

Back to top ↑

Publications

2023

  1. Abe, S., S. Tago, K. Yokoyama, M. Ogawa, T. Takei, S. Imoto, and M. Fuji, Explainable AI for Estimating Pathogenicity of Genetic Variants Using Large-Scale Knowledge Graphs. Cancers (Basel), 2023. 15(4).
  2. Boddu, P.C., A. Gupta, R. Roy, B. De La Pena Avalos, A.O. Herrero, N. Neuenkirchen, J. Zimmer, N. Chandhok, D. King, Y. Nannya, S. Ogawa, H. Lin, M. Simon, E. Dray, G. Kupfer, A.K. Verma, K.M. Neugebauer, and M.M. Pillai, Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape. bioRxiv, 2023.
  3. Daido, Y., H. Sugiura, T. Ishikawa, T. Kuroi, S. Okamoto, N. Nomura, T. Masunari, N. Sezaki, Y. Nannya, S. Ogawa, and M. Tanimoto, Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations. Case Rep Oncol, 2023. 16(1): p. 999-1006.
  4. Edahiro, R., Y. Shirai, Y. Takeshima, S. Sakakibara, Y. Yamaguchi, T. Murakami, T. Morita, Y. Kato, Y.C. Liu, D. Motooka, Y. Naito, A. Takuwa, F. Sugihara, K. Tanaka, J.B. Wing, K. Sonehara, Y. Tomofuji, C.-T.F. Japan, H. Namkoong, H. Tanaka, H. Lee, K. Fukunaga, H. Hirata, Y. Takeda, D. Okuzaki, A. Kumanogoh, and Y. Okada, Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity. Nat Genet, 2023. 55(5): p. 753-767.
  5. Fujita, S., M. Monna-Oiwa, S. Kato, M. Isobe, S. Takahashi, Y. Nannya, and T. Konuma, Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation. Transplant Cell Ther, 2023. 29(9): p. 580 e1-580 e8.
  6. Imi, T., H. Mizumaki, K. Hosomichi, Y. Nannya, Y. Zaimoku, T. Yoroidaka, T. Katagiri, K. Ishiyama, H. Yamazaki, R. Ogawa, M. Kuroiwa, A. Tajima, S. Ogawa, and S. Nakao, Familial immune-mediated aplastic anaemia in six different families. EJHaem, 2023. 4(3): p. 714-718.
  7. Initiative, C.-H.G., A second update on mapping the human genetic architecture of COVID-19. Nature, 2023. 621(7977): p. E7-E26.
  8. Jimbo, K., A. Hattori, S. Koide, T. Ito, K. Sasaki, K. Iwai, Y. Nannya, A. Iwama, A. Tojo, and T. Konuma, Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Leukemia, 2023. 37(1): p. 122-133.
  9. Jimbo, K., M. Yamagishi, Y. Suzuki, K. Suzuki, M. Mizukami, K. Yokoyama, A. Sato, T. Nagamura-Inoue, Y. Nannya, and K. Uchimaru, Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution. EJHaem, 2023. 4(4): p. 1188-1190.
  10. Kaito, Y., E. Sugimoto, F. Nakamura, Y. Tsukune, M. Sasaki, S. Yui, H. Yamaguchi, S. Goyama, Y. Nannya, K. Mitani, H. Tamura, and Y. Imai, Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for NK-cell therapy in acute myeloid leukemia. Haematologica, 2023.
  11. Kataoka, A., C. Mizumoto, J. Kanda, M. Iwasaki, M. Sakurada, T. Oka, M. Fujimoto, Y. Yamamoto, K. Yamashita, Y. Nannya, S. Ogawa, and A. Takaori-Kondo, Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome. Int J Hematol, 2023. 117(6): p. 919-924.
  12. Kawachi, K., X. Tang, R. Kasajima, T. Yamanaka, E. Shimizu, K. Katayama, R. Yamaguchi, K. Yokoyama, K. Yamaguchi, Y. Furukawa, S. Miyano, S. Imoto, E. Yoshioka, K. Washimi, Y. Okubo, S. Sato, T. Yokose, and Y. Miyagi, Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma. Breast Cancer Res Treat, 2023. 202(3): p. 563-573.
  13. Konuma, T., H. Itonaga, K. Ishiyama, N. Doki, N. Uchida, M. Sawa, Y. Katayama, M. Tanaka, Y. Ueda, M. Onizuka, S. Miyakoshi, Y. Ozawa, T. Fukuda, K.I. Matsuoka, J. Tanaka, T. Kimura, T. Ichinohe, and Y. Atsuta, Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome? Bone Marrow Transplant, 2023. 58(8): p. 893-906.
  14. Konuma, T., H. Itonaga, K. Ishiyama, A. Hamamura, N. Uchida, Y. Ozawa, Y. Katayama, M. Sakurai, Y. Ueda, K.I. Matsuoka, T. Kawakita, T. Eto, T. Ara, J. Kanda, M. Onizuka, T. Fukuda, and Y. Atsuta, Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real-world registry study in Japan. Am J Hematol, 2023. 98(4): p. E68-E71.
  15. Konuma, T., J. Kanda, N. Uchida, A. Nishijima, M. Tanaka, Y. Ozawa, M. Sawa, M. Onizuka, S. Ota, Y. Maruyama, Y. Kanda, T. Kawakita, T. Ara, T. Eto, H. Nakamae, T. Kimura, T. Fukuda, Y. Atsuta, T. Donor/Source Working Group of theJapanese Society for, and T. Cellular, Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation. Hematol Oncol, 2023. 41(1): p. 147-158.
  16. Konuma, T., K. Matsuda, Y. Shimomura, S. Tanoue, J. Sugita, Y. Inamoto, M. Hirayama, T. Ara, H. Nakamae, S. Ota, Y. Maruyama, T. Eto, N. Uchida, M. Tanaka, K. Ishiwata, S. Koi, S. Takahashi, Y. Ozawa, M. Onizuka, Y. Kanda, T. Kimura, T. Ichinohe, Y. Atsuta, J. Kanda, and M. Yanada, Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia. Transplant Cell Ther, 2023. 29(6): p. 365 e1-365 e11.
  17. Konuma, T., K. Takano, M. Monna-Oiwa, M. Isobe, S. Kato, S. Takahashi, and Y. Nannya, Clinical implications of augmented renal clearance after unrelated single cord blood transplantation in adults. Int J Hematol, 2023. 118(6): p. 718-725.
  18. Konuma, T., A. Tomonari, J. Ooi, H. Nagayama, T. Kawakita, S. Kato, M. Isobe, M. Monna-Oiwa, A. Tojo, Y. Nannya, and S. Takahashi, Thyrotoxicosis after unrelated cord blood transplantation for adults. Ann Hematol, 2023. 102(3): p. 673-676.
  19. Liu, X., N. Sato, T. Yabushita, J. Li, Y. Jia, M. Tamura, S. Asada, T. Fujino, T. Fukushima, T. Yonezawa, Y. Tanaka, T. Fukuyama, A. Tsuchiya, S. Shikata, H. Iwamura, C. Kinouchi, K. Komatsu, S. Yamasaki, T. Shibata, A.T. Sasaki, J. Schibler, M. Wunderlich, E. O'Brien, B. Mizukawa, J.C. Mulloy, Y. Sugiura, H. Takizawa, T. Shibata, K. Miyake, T. Kitamura, and S. Goyama, IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. EMBO Mol Med, 2023. 15(1): p. e15631.
  20. Makishima, H., R. Saiki, Y. Nannya, S. Korotev, C. Gurnari, J. Takeda, Y. Momozawa, S. Best, P. Krishnamurthy, T. Yoshizato, Y. Atsuta, Y. Shiozawa, Y. Iijima-Yamashita, K. Yoshida, Y. Shiraishi, Y. Nagata, N. Kakiuchi, M. Onizuka, K. Chiba, H. Tanaka, A. Kon, Y. Ochi, M.M. Nakagawa, R. Okuda, T. Mori, A. Yoda, H. Itonaga, Y. Miyazaki, M. Sanada, T. Ishikawa, S. Chiba, H. Tsurumi, S. Kasahara, C. Muller-Tidow, A. Takaori-Kondo, K. Ohyashiki, T. Kiguchi, F. Matsuda, J.H. Jansen, C. Polprasert, P. Blombery, Y. Kamatani, S. Miyano, L. Malcovati, T. Haferlach, M. Kubo, M. Cazzola, A.G. Kulasekararaj, L.A. Godley, J.P. Maciejewski, and S. Ogawa, Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood, 2023. 141(5): p. 534-549.
  21. Matsuda, K., T. Konuma, K. Fuse, M. Masuko, K. Kawamura, M. Hirayama, N. Uchida, K. Ikegame, A. Wake, T. Eto, N. Doki, S. Miyakoshi, M. Tanaka, S. Takahashi, M. Onizuka, K. Kato, T. Kimura, T. Ichinohe, N. Takayama, H. Kobayashi, H. Nakamae, Y. Atsuta, J. Kanda, and M. Yanada, Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study. Br J Haematol, 2023. 201(1): p. 106-113.
  22. Matsuda, K., T. Konuma, and M. Yanada, Cord blood versus haploidentical transplantations for non-remission acute myeloid leukaemia: Authors' reply. Br J Haematol, 2023. 200(5): p. 678-679.
  23. N, H., M. C, R.M. T, S. S, N. S, E.M. K, C.S. S, N. Y, V.D. P, and N.M. R, In Vitro Hepatic Models to Assess Herb-Drug Interactions: Approaches and Challenges. Pharmaceuticals (Basel), 2023. 16(3).
  24. Naka, R., T. Kondo, M. Nishikubo, H. Muranushi, Y. Ueda, T. Oka, F. Wada, J. Kanda, S. Yamamoto, M. Watanabe, S. Okada, K. Imada, Y. Nakabo, Y. Mizutani, Y. Nannya, S. Ogawa, and T. Ishikawa, Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment. Am J Hematol, 2023. 98(9): p. E251-E254.
  25. Nakamura, F., S. Seo, Y. Nannya, R. Ayabe, W. Takahashi, T. Handa, H. Arai, H. Iso, Y. Nakamura, Y. Nakamura, K. Sasaki, M. Ichikawa, Y. Imai, S. Ogawa, and K. Mitani, Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12). Int J Hematol, 2023. 118(3): p. 388-393.
  26. Nannya, Y., Factors associated with clonal hematopoiesis and interaction with marrow environment. J Bone Miner Metab, 2023. 41(3): p. 380-387.
  27. Nannya, Y., M. Tobiasson, S. Sato, E. Bernard, S. Ohtake, J. Takeda, M. Creignou, L. Zhao, M. Kusakabe, Y. Shibata, N. Nakamura, M. Watanabe, N. Hiramoto, Y. Shiozawa, Y. Shiraishi, H. Tanaka, K. Yoshida, N. Kakiuchi, H. Makishima, M. Nakagawa, K. Usuki, M. Watanabe, K. Imada, H. Handa, M. Taguchi, T. Kiguchi, K. Ohyashiki, T. Ishikawa, A. Takaori-Kondo, H. Tsurumi, S. Kasahara, S. Chiba, T. Naoe, S. Miyano, E. Papaemanuil, Y. Miyazaki, E. Hellstrom-Lindberg, and S. Ogawa, Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms. Blood Adv, 2023. 7(14): p. 3624-3636.
  28. Nannya, Y., M. Tobiasson, S. Sato, E. Bernard, S. Ohtake, J. Takeda, M. Creignou, L. Zhao, M. Kusakabe, Y. Shibata, N. Nakamura, M. Watanabe, N. Hiramoto, Y. Shiozawa, Y. Shiraishi, H. Tanaka, K. Yoshida, N. Kakiuchi, H. Makishima, M.M. Nakagawa, K. Usuki, M. Watanabe, K. Imada, H. Handa, M. Taguchi, T. Kiguchi, K. Ohyashiki, T. Ishikawa, A. Takaori-Kondo, H. Tsurumi, S. Kasahara, S. Chiba, T. Naoe, S. Miyano, E. Papaemmanuil, Y. Miyazaki, E. Hellstrom Lindberg, and S. Ogawa, Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms. Blood Adv, 2023.
  29. Nishimura, A., K. Yokoyama, T. Naruto, C. Yamagishi, T. Imamura, H. Nakazono, S. Kimura, M. Ito, M. Sagisaka, Y. Tanaka, J. Piao, Y. Namikawa, M. Yanagimachi, T. Isoda, A. Kanai, H. Matsui, T. Isobe, A. Sato-Otsubo, N. Higuchi, A. Takada, H. Okuno, S. Saito, S. Karakawa, S. Kobayashi, D. Hasegawa, H. Fujisaki, D. Hasegawa, K. Koike, T. Koike, S. Rai, K. Umeda, H. Sano, Y. Sekinaka, A. Ogawa, A. Kinoshita, N. Shiba, M. Miki, F. Kimura, H. Nakayama, Y. Nakazawa, T. Taga, T. Taki, S. Adachi, A. Manabe, K. Koh, Y. Ishida, J. Takita, F. Ishikawa, H. Goto, T. Morio, S. Mizutani, A. Tojo, and M. Takagi, Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type. Sci Adv, 2023. 9(50): p. eadj4407.
  30. Nishimura, T., N. Kakiuchi, K. Yoshida, T. Sakurai, T.R. Kataoka, E. Kondoh, Y. Chigusa, M. Kawai, M. Sawada, T. Inoue, Y. Takeuchi, H. Maeda, S. Baba, Y. Shiozawa, R. Saiki, M.M. Nakagawa, Y. Nannya, Y. Ochi, T. Hirano, T. Nakagawa, Y. Inagaki-Kawata, K. Aoki, M. Hirata, K. Nanki, M. Matano, M. Saito, E. Suzuki, M. Takada, M. Kawashima, K. Kawaguchi, K. Chiba, Y. Shiraishi, J. Takita, S. Miyano, M. Mandai, T. Sato, K. Takeuchi, H. Haga, M. Toi, and S. Ogawa, Evolutionary histories of breast cancer and related clones. Nature, 2023. 620(7974): p. 607-614.
  31. Sato, A., M. Kobayashi, N. Yusa, M. Ogawa, E. Shimizu, T. Kawamata, K. Yokoyama, Y. Ota, T. Ichinohe, H. Ohno, Y. Mori, E. Sakaida, T. Kondo, S. Imoto, Y. Nannya, K. Mitani, and A. Tojo, Clinical and prognostic features of Langerhans cell histiocytosis in adults. Cancer Sci, 2023. 114(9): p. 3687-3697.
  32. Shimizu, Y., H. Nishikii, T. Iitsuka, R. Matsuoka, N. Kurita, T. Sakamoto, Y. Yokoyama, T. Kato, Y. Suehara, K. Hattori, Y. Maruyama, Y. Nannya, S. Ogawa, M. Sakata-Yanagimoto, S. Chiba, and N. Obara, [Hematopoietic recovery by ASXL1-mutated clones after immune suppressive therapy in a patient with severe aplastic anemia]. Rinsho Ketsueki, 2023. 64(1): p. 49-53.
  33. Shingai, N., H. Mizumaki, Y. Najima, Y. Yamada, D.C. Tran, K. Haraguchi, T. Toya, Y. Okuyama, N. Doki, Y. Nannya, S. Ogawa, and S. Nakao, Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria. Front Immunol, 2023. 14: p. 1329403.
  34. Suzuki, M., R. Kasajima, T. Yokose, E. Shimizu, S. Hatakeyama, K. Yamaguchi, K. Yokoyama, K. Katayama, R. Yamaguchi, Y. Furukawa, S. Miyano, S. Imoto, A. Shinozaki-Ushiku, T. Ushiku, and Y. Miyagi, KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component. Transl Lung Cancer Res, 2023. 12(8): p. 1738-1751.
  35. Takahashi, R., Y. Matsubara, S. Takahashi, K. Yokoyama, L.L. Ahyoung, M. Koga, H. Sakamoto, N. Boku, D. Shida, and H. Yotsuyanagi, Refractory Intestinal Behcet-Like Disease Associated with Trisomy 8 Myelodysplastic Syndrome Resolved by Parenteral Nutrition. Case Rep Gastroenterol, 2023. 17(1): p. 287-293.
  36. Toratani, K., M. Watanabe, J. Kanda, T. Oka, M. Hyuga, Y. Arai, M. Iwasaki, M. Sakurada, Y. Nannya, S. Ogawa, T. Yamada, and A. Takaori-Kondo, Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations. Int J Hematol, 2023. 118(3): p. 400-405.
  37. Xi, Q., H. Kage, M. Ogawa, A. Matsunaga, A. Nishijima, K. Sone, K. Kawana, and K. Oda, Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers (Basel), 2023. 16(1).
  38. Y, N., Commentary on TP53 Mutated Myeloid Malignancies and Their Treatment Strategy,. J Blood Lymph, 2023. 13: p. 306.
  39. Yabushita, T., T. Chinen, A. Nishiyama, S. Asada, R. Shimura, T. Isobe, K. Yamamoto, N. Sato, Y. Enomoto, Y. Tanaka, T. Fukuyama, H. Satoh, K. Kato, K. Saitoh, T. Ishikawa, T. Soga, Y. Nannya, T. Fukagawa, M. Nakanishi, D. Kitagawa, T. Kitamura, and S. Goyama, Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Cell Rep, 2023. 42(9): p. 113098.
  40. Yamada, T., N. Hiramoto, T. Mori, D. Yamashita, Y. Tai, R. Yamamoto, M. Nishikubo, H. Maruoka, K. Sakamoto, K. Takeuchi, Y. Nannya, S. Ogawa, and T. Ishikawa, Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis. Blood Cancer J, 2023. 13(1): p. 119.
  41. Yanada, M., Y. Shimomura, S. Mizuno, K. Matsuda, T. Kondo, N. Doki, M. Tanaka, T. Fukuda, T. Ara, N. Uchida, M. Onizuka, M. Sawa, Y. Ozawa, N. Hiramoto, S. Ota, J. Kanda, Y. Kanda, T. Ichinohe, S. Okamoto, Y. Atsuta, and T. Konuma, External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia. Bone Marrow Transplant, 2023. 58(10): p. 1096-1103.
  42. Yanada, M., S. Yamasaki, T. Kondo, T. Kawata, K. Harada, N. Uchida, N. Doki, S. Yoshihara, Y. Katayama, T. Eto, M. Tanaka, S. Takada, T. Kawakita, T. Nishida, S. Ota, K. Serizawa, M. Onizuka, Y. Kanda, T. Fukuda, Y. Atsuta, and T. Konuma, Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission. Leukemia, 2023.
  43. Yanada, M., S. Yamasaki, T. Konuma, S. Mizuno, N. Uchida, D. Onai, T. Fukuda, M. Tanaka, Y. Ozawa, T. Eto, K. Ikegame, M. Sawa, Y. Katayama, T. Kawakita, M. Onizuka, Y. Kanda, T. Ichinohe, Y. Atsuta, and S. Yano, Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. Int J Hematol, 2023. 117(3): p. 398-408.

Back to top ↑

Publications

2022

  1. Adachi, E., E. Nagai, M. Saito, M. Isobe, T. Konuma, M. Koga, T. Tsutsumi, Y. Nannya, and H. Yotsuyanagi, Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron. J Infect Chemother, 2022. 28(7): p. 1015-1017.
  2. Arita, K., J. Murakami, N. Iwaki, N. Hosono, T. Tasaki, T. Tsujikawa, H. Okazawa, T. Imi, Y. Nannya, S. Ogawa, and S. Nakao, An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly. Br J Haematol, 2022. 198(5): p. e75-e77.
  3. Asimomitis, G., A.G. Deslauriers, A.G. Kotini, E. Bernard, D. Esposito, M. Olszewska, N. Spyrou, J. Arango Ossa, T. Mortera-Blanco, R. Koche, Y. Nannya, L. Malcovati, S. Ogawa, M. Cazzola, S.A. Aaronson, E. Hellstrom-Lindberg, E. Papaemmanuil, and E.P. Papapetrou, Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs. Blood Adv, 2022. 6(10): p. 2992-3005.
  4. Bernard, E., H. Tuechler, P.L. Greenberg, R.P. Hasserjian, J.E. Arango Ossa, Y. Nannya, S.M. Devlin, M. Creignou, P. Pinel, L. Monnier, G. Gundem, J.S. Medina-Martinez, D. Domenico, M. Jadersten, U. Germing, G. Sanz, A.A. van de Loosdrecht, O. Kosmider, M.Y. Follo, F. Thol, L. Zamora, R.F. Pinheiro, A. Pellagatti, H.K. Elias, D. Haase, C. Ganster, L. Ades, M. Tobiasson, L. Palomo, M.G. Della Porta, A. Takaori-Kondo, T. Ishikawa, S. Chiba, S. Kasahara, Y. Miyazaki, A. Viale, K. Huberman, P. Fenaux, M. Belickova, M.R. Savona, V.M. Klimek, F.P.S. Santos, J. Boultwood, I. Kotsianidis, V. Santini, F. Sole, U. Platzbecker, M. Heuser, P. Valent, K. Ohyashiki, C. Finelli, M.T. Voso, L.Y. Shih, M. Fontenay, J.H. Jansen, J. Cervera, N. Gattermann, B.L. Ebert, R. Bejar, L. Malcovati, M. Cazzola, S. Ogawa, E. Hellstrom-Lindberg, and E. Papaemmanuil, Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. NEJM Evid, 2022. 1(7): p. EVIDoa2200008.
  5. Chawla, J., N. Y, S.S. Bakshi, V.K. Kalidoss, S. Yadav, S. Polineni, and C. Jayam, Oral manifestations associated with COVID-19 disease: An observational cross sectional study. J Oral Biol Craniofac Res, 2022. 12(2): p. 279-283.
  6. Fukushi, K., T. Konuma, M. Monna-Oiwa, M. Isobe, S. Kato, S. Kuroda, S. Takahashi, and Y. Nannya, Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation. Transplant Cell Ther, 2022. 28(6): p. 339 e1-339 e7.
  7. Fukuyama, T., T. Kitamura, and T. Kozu, UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8. Int J Hematol, 2022. 115(5): p. 686-693.
  8. Guzzi, N., S. Muthukumar, M. Ciesla, G. Todisco, P.C.T. Ngoc, M. Madej, R. Munita, S. Fazio, S. Ekstrom, T. Mortera-Blanco, M. Jansson, Y. Nannya, M. Cazzola, S. Ogawa, L. Malcovati, E. Hellstrom-Lindberg, M. Dimitriou, and C. Bellodi, Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nat Cell Biol, 2022. 24(3): p. 299-306.
  9. Hayashi, Y., K.C. Kawabata, Y. Tanaka, Y. Uehara, Y. Mabuchi, K. Murakami, A. Nishiyama, S. Kiryu, Y. Yoshioka, Y. Ota, T. Sugiyama, K. Mikami, M. Tamura, T. Fukushima, S. Asada, R. Takeda, Y. Kunisaki, T. Fukuyama, K. Yokoyama, T. Uchida, M. Hagihara, N. Ohno, K. Usuki, A. Tojo, Y. Katayama, S. Goyama, F. Arai, T. Tamura, T. Nagasawa, T. Ochiya, D. Inoue, and T. Kitamura, MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis. Cell Rep, 2022. 39(6): p. 110805.
  10. Heissig, B., Y. Salama, R. Iakoubov, J.J. Vehreschild, R. Rios, T. Nogueira, M. Vehreschild, M. Stecher, H. Mori, J. Lanznaster, E. Adachi, C. Jakob, Y. Tabe, M. Ruethrich, S. Borgmann, T. Naito, K. Wille, S. Valenti, M. Hower, N. Hattori, S. Rieg, T. Nagaoka, B.E. Jensen, H. Yotsuyanagi, B. Hertenstein, H. Ogawa, C. Wyen, E. Kominami, C. Roemmele, S. Takahashi, J. Rupp, K. Takahashi, F. Hanses, K. Hattori, and G. On Behalf Of The Leoss Study, COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity. Biomedicines, 2022. 10(10).
  11. Heissig, B., Y. Salama, M. Tateno, S. Takahashi, and K. Hattori, siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft-versus-host disease. EJHaem, 2022. 3(3): p. 849-861.
  12. Ishitsuka, K., Y. Yoshizawa, H. Nishikii, M. Kusakabe, Y. Ito, Y. Inadome, T. Sakamoto, T. Kato, N. Kurita, Y. Yokoyama, N. Obara, Y. Hasegawa, Y. Nannya, S. Ogawa, M. Sakata-Yanagimoto, and S. Chiba, Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation. Leuk Lymphoma, 2022: p. 1-5.
  13. Ishiyama, K., T.C. Dung, T. Imi, K. Hosokawa, Y. Nannya, H. Yamazaki, S. Ogawa, and S. Nakao, Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia. EJHaem, 2022. 3(4): p. 1116-1125.
  14. Isobe, T., M. Takagi, A. Sato-Otsubo, A. Nishimura, G. Nagae, C. Yamagishi, M. Tamura, Y. Tanaka, S. Asada, R. Takeda, A. Tsuchiya, X. Wang, K. Yoshida, Y. Nannya, H. Ueno, R. Akazawa, I. Kato, T. Mikami, K. Watanabe, M. Sekiguchi, M. Seki, S. Kimura, M. Hiwatari, M. Kato, S. Fukuda, K. Tatsuno, S. Tsutsumi, A. Kanai, T. Inaba, Y. Shiozawa, Y. Shiraishi, K. Chiba, H. Tanaka, R.S. Kotecha, M.N. Cruickshank, F. Ishikawa, T. Morio, M. Eguchi, T. Deguchi, N. Kiyokawa, Y. Arakawa, K. Koh, Y. Aoki, T. Ishihara, D. Tomizawa, T. Miyamura, E. Ishii, S. Mizutani, N.K. Wilson, B. Gottgens, S. Miyano, T. Kitamura, S. Goyama, A. Yokoyama, H. Aburatani, S. Ogawa, and J. Takita, Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia. Nat Commun, 2022. 13(1): p. 4501.
  15. Izutsu, K., S. Makita, K. Nosaka, M. Yoshimitsu, A. Utsunomiya, S. Kusumoto, S. Morishima, K. Tsukasaki, T. Kawamata, T. Ono, S. Rai, H. Katsuya, J. Ishikawa, H. Yamada, K. Kato, M. Tachibana, Y. Kakurai, N. Adachi, K. Tobinai, K. Yonekura, and K. Ishitsuka, An Open-Label, Single-Arm, Phase 2 Trial of Valemetostat in Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma. Blood, 2022.
  16. Jimbo, K., A. Hattori, S. Koide, T. Ito, K. Sasaki, K. Iwai, Y. Nannya, A. Iwama, A. Tojo, and T. Konuma, Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Leukemia, 2022.
  17. Jimbo, K., Y. Nakajima-Takagi, T. Ito, S. Koide, Y. Nannya, A. Iwama, A. Tojo, and T. Konuma, Immunoglobulin superfamily member 8 maintains myeloid leukemia stem cells through inhibition of beta-catenin degradation. Leukemia, 2022. 36(6): p. 1550-1562.
  18. Kamoi, K., T. Watanabe, K. Uchimaru, A. Okayama, S. Kato, T. Kawamata, H. Kurozumi-Karube, N. Horiguchi, Y. Zong, Y. Yamano, I. Hamaguchi, Y. Nannya, A. Tojo, and K. Ohno-Matsui, Updates on HTLV-1 Uveitis. Viruses, 2022. 14(4).
  19. Kanda, J., H. Hayashi, A. Ruggeri, F. Kimura, F. Volt, S. Takahashi, S. Kako, K. Tozatto-Maio, M. Yanada, G. Sanz, N. Uchida, E. Angelucci, S. Kato, M. Mohty, E. Forcade, M. Tanaka, J. Sierra, T. Ohta, R. Saccardi, T. Fukuda, T. Ichinohe, T. Kimura, V. Rocha, S. Okamoto, A. Nagler, Y. Atsuta, and E. Gluckman, The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations. Bone Marrow Transplant, 2022. 57(1): p. 57-64.
  20. Kanda, J., S. Hirabayashi, H. Yokoyama, T. Kawase, H. Tanaka, N. Uchida, S. Taniguchi, S. Takahashi, M. Onizuka, M. Tanaka, Y. Sugio, T. Eto, Y. Kanda, T. Kimura, T. Ichinohe, Y. Atsuta, S. Morishima, T. Japanese Society for, and H.L.A.W.G. Cellular Therapy's, Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation. Transplant Cell Ther, 2022. 28(7): p. 398 e1-398 e9.
  21. Katagiri, T., J.L. Espinoza, M. Uemori, H. Ikeda, K. Hosokawa, K. Ishiyama, T. Yoroidaka, T. Imi, H. Takamatsu, T. Ozawa, H. Kishi, Y. Yamamoto, M.I. Elbadry, Y. Yoshida, K. Chonabayashi, K. Takenaka, K. Akashi, Y. Nannya, S. Ogawa, and S. Nakao, Hematopoietic stem progenitor cells with malignancy-related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4. EJHaem, 2022. 3(3): p. 669-680.
  22. Kato, S., T. Konuma, M. Monna-Oiwa, M. Isobe, S. Takahashi, and Y. Nannya, Higher Cryopreserved CD34(+) Cell Dose Is Associated with Decreased Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Single-Unit Cord Blood Transplantation in Adults Given Prophylactic Ursodeoxycholic Acid and Intravenous Heparin. Transplant Cell Ther, 2022. 28(11): p. 779 e1-779 e9.
  23. Kazama, S., K. Yokoyama, T. Ueki, H. Kazumoto, H. Satomi, M. Sumi, I. Ito, N. Yusa, R. Kasajima, E. Shimizu, R. Yamaguchi, S. Imoto, S. Miyano, Y. Tanaka, T. Denda, Y. Ota, A. Tojo, and H. Kobayashi, Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia. Front Oncol, 2022. 12: p. 974307.
  24. Kimura, S.I., H. Shimizu, T. Miyazaki, M. Sakurai, S. Tanoue, K. Kayamori, C. Ohwada, K. Yoshimura, H. Nakasone, T. Ohashi, K. Shono, T. Tachibana, K. Hatano, K. Okada, Y. Kimura, S. Seo, N. Doki, M. Tanaka, Y. Hatta, S. Takahashi, Y. Kanda, and T. Kanto Study Group for Cell, Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant, 2022.
  25. Kobayashi, A., R. Ohtaka, T. Toki, J. Hara, H. Muramatsu, R. Kanezaki, Y. Takahashi, T. Sato, T. Kamio, K. Kudo, S. Sasaki, T. Yoshida, T. Utsugisawa, H. Kanno, K. Yoshida, Y. Nannya, Y. Takahashi, S. Kojima, S. Miyano, S. Ogawa, K. Terui, and E. Ito, Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond-Blackfan anaemia. EJHaem, 2022. 3(1): p. 163-167.
  26. Kobayashi, S., Y. Kanda, T. Konuma, Y. Inamoto, K. Matsumoto, N. Uchida, K. Ikegame, T. Miyamoto, N. Doki, H. Nakamae, Y. Katayama, S. Takahashi, S. Shiratori, S. Saito, T. Kawakita, J. Kanda, T. Fukuda, Y. Atsuta, and F. Kimura, Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone Marrow Transplant, 2022. 57(1): p. 43-50.
  27. Kogure, Y., T. Kameda, J. Koya, M. Yoshimitsu, K. Nosaka, J.I. Yasunaga, Y. Imaizumi, M. Watanabe, Y. Saito, Y. Ito, M.B. McClure, M. Tabata, S. Shingaki, K. Yoshifuji, K. Chiba, A. Okada, N. Kakiuchi, Y. Nannya, A. Kamiunten, Y. Tahira, K. Akizuki, M. Sekine, K. Shide, T. Hidaka, Y. Kubuki, A. Kitanaka, M. Hidaka, N. Nakano, A. Utsunomiya, R.A. Sica, A. Acuna-Villaorduna, M. Janakiram, U. Shah, J.C. Ramos, T. Shibata, K. Takeuchi, A. Takaori-Kondo, Y. Miyazaki, M. Matsuoka, K. Ishitsuka, Y. Shiraishi, S. Miyano, S. Ogawa, B.H. Ye, K. Shimoda, and K. Kataoka, Whole-genome landscape of adult T-cell leukemia/lymphoma. Blood, 2022. 139(7): p. 967-982.
  28. Konuma, T., K. Harada, T. Kondo, M. Masuko, N. Uchida, S. Yano, T. Kawakita, M. Onizuka, S. Ota, E. Sakaida, S. Miyakoshi, Y. Ozawa, Y. Imamura, T. Kimura, Y. Kanda, T. Fukuda, Y. Atsuta, M. Yanada, T. Adult Acute Myeloid Leukemia Working Group of the Japanese Society for, and T. Cellular, Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years. Bone Marrow Transplant, 2022. 57(12): p. 1848-1850.
  29. Konuma, T., M. Isobe, S. Kato, S. Takahashi, and Y. Nannya, Respiratory syncytial virus pneumonia in an adult cord blood transplant recipient during the SARS-CoV-2 outbreak. EJHaem, 2022. 3(1): p. 261-262.
  30. Konuma, T., J. Kanda, N. Uchida, A. Nishijima, M. Tanaka, Y. Ozawa, M. Sawa, M. Onizuka, S. Ota, Y. Maruyama, Y. Kanda, T. Kawakita, T. Ara, T. Eto, H. Nakamae, T. Kimura, T. Fukuda, Y. Atsuta, T. Donor/Source Working Group of theJapanese Society for, and T. Cellular, Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation. Hematol Oncol, 2022.
  31. Konuma, T., S. Mizuno, K. Harada, N. Uchida, S. Takahashi, T. Eto, S. Ota, H. Kobayashi, Y. Katayama, Y. Mori, Y. Maruyama, M. Onizuka, A. Yonezawa, T. Kawakita, T. Kimura, Y. Kanda, T. Fukuda, Y. Atsuta, M. Yanada, T. Adult Acute Myeloid Leukemia Working Group of the Japanese Society for, and T. Cellular, Reducing Mortality of Single-Unit Unrelated Cord Blood Transplantation for Relapsed Acute Myeloid Leukemia after a Previous Allogeneic Transplantation: A Real-World Retrospective Study Over the Past 19 Years in Japan. Transplant Cell Ther, 2022. 28(11): p. 777 e1-777 e11.
  32. Konuma, T., S. Mizuno, T. Kondo, Y. Arai, N. Uchida, S. Takahashi, M. Tanaka, T. Kuriyama, S. Miyakoshi, M. Onizuka, S. Ota, Y. Sugio, Y. Kouzai, T. Kawakita, H. Kobayashi, Y. Ozawa, T. Kimura, T. Ichinohe, Y. Atsuta, M. Yanada, T. Adult Acute Myeloid Leukemia Working Group of the Japanese Society for, and T. Cellular, Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia. Blood Cancer J, 2022. 12(5): p. 81.
  33. Konuma, T., M. Monna-Oiwa, K. Takano, M. Isobe, S. Kato, S. Takahashi, and Y. Nannya, Optimal time and threshold of absolute lymphocyte count recovery as a prognostic factor after single-unit cord blood transplantation in adults. EJHaem, 2022. 3(1): p. 191-198.
  34. Konuma, T., J. Ooi, M. Monna-Oiwa, M. Isobe, A. Tomonari, S. Kato, T. Iseki, Y. Nannya, A. Tojo, and S. Takahashi, Total body irradiation-based versus busulfan-based myeloablative conditioning for single-unit cord blood transplantation in adults. Leuk Lymphoma, 2022. 63(5): p. 1191-1201.
  35. Konuma, T., Y. Shimomura, K. Ishiyama, T. Ara, H. Nakamae, N. Hiramoto, T. Eto, Y. Maruyama, K. Nagafuji, J. Ishikawa, N. Uchida, M. Tanaka, M. Onizuka, Y. Ueda, N. Anzai, T. Kimura, Y. Kanda, T. Fukuda, and Y. Atsuta, Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT). Am J Hematol, 2022. 97(12): p. E447-E450.
  36. Konuma, T., A. Tomonari, J. Ooi, H. Nagayama, T. Kawakita, S. Kato, M. Isobe, M. Monna-Oiwa, A. Tojo, Y. Nannya, and S. Takahashi, Thyrotoxicosis after unrelated cord blood transplantation for adults. Ann Hematol, 2022.
  37. Liu, X., N. Sato, Y. Shimosato, T.W. Wang, T. Denda, Y.H. Chang, T. Yabushita, T. Fujino, S. Asada, Y. Tanaka, T. Fukuyama, Y. Enomoto, Y. Ota, T. Sakamoto, T. Kitamura, and S. Goyama, CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression. Cancer Sci, 2022. 113(4): p. 1182-1194.
  38. Makishima, H., R. Saiki, Y. Nannya, S.C. Korotev, C. Gurnari, J. Takeda, Y. Momozawa, S. Best, P. Krishnamurthy, T. Yoshizato, Y. Atsuta, Y. Shiozawa, Y. Iijima-Yamashita, K. Yoshida, Y. Shiraishi, Y. Nagata, N. Kakiuchi, M. Onizuka, K. Chiba, H. Tanaka, A. Kon, Y. Ochi, M.M. Nakagawa, R. Okuda, T. Mori, A. Yoda, H. Itonaga, Y. Miyazaki, M. Sanada, T. Ishikawa, S. Chiba, H. Tsurumi, S. Kasahara, C. Muller-Tidow, A. Takaori-Kondo, K. Ohyashiki, T. Kiguchi, F. Matsuda, J.H. Jansen, C. Polprasert, P. Blombery, Y. Kamatani, S. Miyano, L. Malcovati, T. Haferlach, M. Kubo, M. Cazzola, A.G. Kulasekararaj, L.A. Godley, J.P. Maciejewski, and S. Ogawa, Germline DDX41 mutations define a unique subtype of myeloid neoplasms. Blood, 2022.
  39. Matsuda, K., T. Konuma, K. Fuse, M. Masuko, K. Kawamura, M. Hirayama, N. Uchida, K. Ikegame, A. Wake, T. Eto, N. Doki, S. Miyakoshi, M. Tanaka, S. Takahashi, M. Onizuka, K. Kato, T. Kimura, T. Ichinohe, N. Takayama, H. Kobayashi, H. Nakamae, Y. Atsuta, J. Kanda, and M. Yanada, Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study. Br J Haematol, 2022.
  40. Matsuda, K., T. Konuma, and M. Yanada, Cord blood versus haploidentical transplantations for non-remission acute myeloid leukaemia: Authors' reply. Br J Haematol, 2022.
  41. Mizukami, M., T. Konuma, E. Nagai, M. Monna-Oiwa, M. Isobe, S. Kato, S. Takahashi, A. Tojo, and Y. Nannya, Early prediction of neutrophil engraftment using manual leukocyte differential count after cord blood transplantation. Int J Lab Hematol, 2022. 44(4): p. e156-e159.
  42. Mizuno, S., A. Takami, K. Kawamura, Y. Shimomura, Y. Arai, T. Konuma, Y. Ozawa, M. Sawa, S. Ota, S. Takahashi, N. Anzai, N. Hiramoto, M. Onizuka, H. Nakamae, M. Tanaka, M. Murata, T. Kimura, J. Kanda, T. Fukuda, Y. Atsuta, and M. Yanada, Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation. Transplant Cell Ther, 2022. 28(11): p. 775 e1-775 e9.
  43. Morita, Y., Y. Nannya, M. Ichikawa, H. Hanamoto, H. Shibayama, Y. Maeda, T. Hata, T. Miyamoto, H. Kawabata, K. Takeuchi, H. Tanaka, J. Kishimoto, S. Miyano, I. Matsumura, S. Ogawa, K. Akashi, Y. Kanakura, and K. Mitani, ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. Int J Hematol, 2022. 116(5): p. 659-668.
  44. Nagahata, Y., K. Masuda, Y. Nishimura, T. Ikawa, S. Kawaoka, T. Kitawaki, Y. Nannya, S. Ogawa, H. Suga, Y. Satou, A. Takaori-Kondo, and H. Kawamoto, Tracing the evolutionary history of blood cells to the unicellular ancestor of animals. Blood, 2022. 140(24): p. 2611-2625.
  45. Nagai, H., M. Saito, E. Adachi, Y. Sakai-Tagawa, S. Yamayoshi, M. Kiso, T. Kawamata, M. Koga, Y. Kawaoka, T. Tsutsumi, and H. Yotsuyanagi, Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy. Jpn J Infect Dis, 2022. 75(6): p. 608-611.
  46. Nagamura-Inoue, T., S. Kato, Y. Najima, M. Isobe, N. Doki, H. Yamamoto, N. Uchida, A. Takahashi, A. Hori, M. Nojima, K. Ohashi, F. Nagamura, and A. Tojo, Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease. Int J Hematol, 2022. 116(5): p. 754-769.
  47. Nakamura, F., Y. Nakamura, Y. Nannya, H. Arai, K. Shimbo, Y. Nakamura, S. Seo, K. Sasaki, M. Ichikawa, S. Ogawa, and K. Mitani, Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma. Leuk Res Rep, 2022. 17: p. 100305.
  48. Namkoong, H., R. Edahiro, T. Takano, H. Nishihara, Y. Shirai, K. Sonehara, H. Tanaka, S. Azekawa, Y. Mikami, H. Lee, T. Hasegawa, K. Okudela, D. Okuzaki, D. Motooka, M. Kanai, T. Naito, K. Yamamoto, Q.S. Wang, R. Saiki, R. Ishihara, Y. Matsubara, J. Hamamoto, H. Hayashi, Y. Yoshimura, N. Tachikawa, E. Yanagita, T. Hyugaji, E. Shimizu, K. Katayama, Y. Kato, T. Morita, K. Takahashi, N. Harada, T. Naito, M. Hiki, Y. Matsushita, H. Takagi, R. Aoki, A. Nakamura, S. Harada, H. Sasano, H. Kabata, K. Masaki, H. Kamata, S. Ikemura, S. Chubachi, S. Okamori, H. Terai, A. Morita, T. Asakura, J. Sasaki, H. Morisaki, Y. Uwamino, K. Nanki, S. Uchida, S. Uno, T. Nishimura, T. Ishiguro, T. Isono, S. Shibata, Y. Matsui, C. Hosoda, K. Takano, T. Nishida, Y. Kobayashi, Y. Takaku, N. Takayanagi, S. Ueda, A. Tada, M. Miyawaki, M. Yamamoto, E. Yoshida, R. Hayashi, T. Nagasaka, S. Arai, Y. Kaneko, K. Sasaki, E. Tagaya, M. Kawana, K. Arimura, K. Takahashi, T. Anzai, S. Ito, A. Endo, Y. Uchimura, Y. Miyazaki, T. Honda, T. Tateishi, S. Tohda, N. Ichimura, K. Sonobe, C.T. Sassa, J. Nakajima, Y. Nakano, Y. Nakajima, R. Anan, R. Arai, Y. Kurihara, Y. Harada, K. Nishio, T. Ueda, M. Azuma, R. Saito, T. Sado, Y. Miyazaki, R. Sato, Y. Haruta, T. Nagasaki, Y. Yasui, Y. Hasegawa, Y. Mutoh, T. Kimura, T. Sato, R. Takei, S. Hagimoto, Y. Noguchi, Y. Yamano, H. Sasano, S. Ota, Y. Nakamori, K. Yoshiya, F. Saito, T. Yoshihara, D. Wada, H. Iwamura, S. Kanayama, S. Maruyama, T. Yoshiyama, K. Ohta, H. Kokuto, H. Ogata, Y. Tanaka, K. Arakawa, M. Shimoda, T. Osawa, H. Tateno, I. Hase, S. Yoshida, S. Suzuki, M. Kawada, H. Horinouchi, F. Saito, K. Mitamura, M. Hagihara, J. Ochi, T. Uchida, R. Baba, D. Arai, T. Ogura, H. Takahashi, S. Hagiwara, G. Nagao, S. Konishi, I. Nakachi, K. Murakami, M. Yamada, H. Sugiura, H. Sano, S. Matsumoto, N. Kimura, Y. Ono, H. Baba, Y. Suzuki, S. Nakayama, K. Masuzawa, S. Namba, K. Suzuki, Y. Naito, Y.C. Liu, A. Takuwa, F. Sugihara, J.B. Wing, S. Sakakibara, N. Hizawa, T. Shiroyama, S. Miyawaki, Y. Kawamura, A. Nakayama, H. Matsuo, Y. Maeda, T. Nii, Y. Noda, T. Niitsu, Y. Adachi, T. Enomoto, S. Amiya, R. Hara, Y. Yamaguchi, T. Murakami, T. Kuge, K. Matsumoto, Y. Yamamoto, M. Yamamoto, M. Yoneda, T. Kishikawa, S. Yamada, S. Kawabata, N. Kijima, M. Takagaki, N. Sasa, Y. Ueno, M. Suzuki, N. Takemoto, H. Eguchi, T. Fukusumi, T. Imai, M. Fukushima, H. Kishima, H. Inohara, K. Tomono, K. Kato, M. Takahashi, F. Matsuda, H. Hirata, Y. Takeda, H. Koh, T. Manabe, Y. Funatsu, F. Ito, T. Fukui, K. Shinozuka, S. Kohashi, M. Miyazaki, T. Shoko, M. Kojima, T. Adachi, M. Ishikawa, K. Takahashi, T. Inoue, T. Hirano, K. Kobayashi, H. Takaoka, K. Watanabe, N. Miyazawa, Y. Kimura, R. Sado, H. Sugimoto, A. Kamiya, N. Kuwahara, A. Fujiwara, T. Matsunaga, Y. Sato, T. Okada, Y. Hirai, H. Kawashima, A. Narita, K. Niwa, Y. Sekikawa, K. Nishi, M. Nishitsuji, M. Tani, J. Suzuki, H. Nakatsumi, T. Ogura, H. Kitamura, E. Hagiwara, K. Murohashi, H. Okabayashi, T. Mochimaru, S. Nukaga, R. Satomi, Y. Oyamada, N. Mori, T. Baba, Y. Fukui, M. Odate, S. Mashimo, Y. Makino, K. Yagi, M. Hashiguchi, J. Kagyo, T. Shiomi, S. Fuke, H. Saito, T. Tsuchida, S. Fujitani, M. Takita, D. Morikawa, T. Yoshida, T. Izumo, M. Inomata, N. Kuse, N. Awano, M. Tone, A. Ito, Y. Nakamura, K. Hoshino, J. Maruyama, H. Ishikura, T. Takata, T. Odani, M. Amishima, T. Hattori, Y. Shichinohe, T. Kagaya, T. Kita, K. Ohta, S. Sakagami, K. Koshida, K. Hayashi, T. Shimizu, Y. Kozu, H. Hiranuma, Y. Gon, N. Izumi, K. Nagata, K. Ueda, R. Taki, S. Hanada, K. Kawamura, K. Ichikado, K. Nishiyama, H. Muranaka, K. Nakamura, N. Hashimoto, K. Wakahara, K. Sakamoto, N. Omote, A. Ando, N. Kodama, Y. Kaneyama, S. Maeda, T. Kuraki, T. Matsumoto, K. Yokote, T.A. Nakada, R. Abe, T. Oshima, T. Shimada, M. Harada, T. Takahashi, H. Ono, T. Sakurai, T. Shibusawa, Y. Kimizuka, A. Kawana, T. Sano, C. Watanabe, R. Suematsu, H. Sageshima, A. Yoshifuji, K. Ito, S. Takahashi, K. Ishioka, M. Nakamura, M. Masuda, A. Wakabayashi, H. Watanabe, S. Ueda, M. Nishikawa, Y. Chihara, M. Takeuchi, K. Onoi, J. Shinozuka, A. Sueyoshi, Y. Nagasaki, M. Okamoto, S. Ishihara, M. Shimo, Y. Tokunaga, Y. Kusaka, T. Ohba, S. Isogai, A. Ogawa, T. Inoue, S. Fukuyama, Y. Eriguchi, A. Yonekawa, O.K. Kan, K. Matsumoto, K. Kanaoka, S. Ihara, K. Komuta, Y. Inoue, S. Chiba, K. Yamagata, Y. Hiramatsu, H. Kai, K. Asano, T. Oguma, Y. Ito, S. Hashimoto, M. Yamasaki, Y. Kasamatsu, Y. Komase, N. Hida, T. Tsuburai, B. Oyama, M. Takada, H. Kanda, Y. Kitagawa, T. Fukuta, T. Miyake, S. Yoshida, S. Ogura, S. Abe, Y. Kono, Y. Togashi, H. Takoi, R. Kikuchi, S. Ogawa, T. Ogata, S. Ishihara, A. Kanehiro, S. Ozaki, Y. Fuchimoto, S. Wada, N. Fujimoto, K. Nishiyama, M. Terashima, S. Beppu, K. Yoshida, O. Narumoto, H. Nagai, N. Ooshima, M. Motegi, A. Umeda, K. Miyagawa, H. Shimada, M. Endo, Y. Ohira, M. Watanabe, S. Inoue, A. Igarashi, M. Sato, H. Sagara, A. Tanaka, S. Ohta, T. Kimura, Y. Shibata, Y. Tanino, T. Nikaido, H. Minemura, Y. Sato, Y. Yamada, T. Hashino, M. Shinoki, H. Iwagoe, H. Takahashi, K. Fujii, H. Kishi, M. Kanai, T. Imamura, T. Yamashita, M. Yatomi, T. Maeno, S. Hayashi, M. Takahashi, M. Kuramochi, I. Kamimaki, Y. Tominaga, T. Ishii, M. Utsugi, A. Ono, T. Tanaka, T. Kashiwada, K. Fujita, Y. Saito, M. Seike, H. Watanabe, H. Matsuse, N. Kodaka, C. Nakano, T. Oshio, T. Hirouchi, S. Makino, M. Egi, P. Biobank Japan, Y. Omae, Y. Nannya, T. Ueno, K. Katayama, M. Ai, Y. Fukui, A. Kumanogoh, T. Sato, N. Hasegawa, K. Tokunaga, M. Ishii, R. Koike, Y. Kitagawa, A. Kimura, S. Imoto, S. Miyano, S. Ogawa, T. Kanai, K. Fukunaga and Y. Okada, DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature, 2022. 609(7928): p. 754-760.
  49. Nannya, Y., Factors associated with clonal hematopoiesis and interaction with marrow environment. J Bone Miner Metab, 2022.
  50. Nannya, Y., [NGS-based multi-gene panel testing in hematological malignancies: germline variants and related issues]. Rinsho Ketsueki, 2022. 63(4): p. 308-312.
  51. Nannya Y, Viswabandya A, and Lu P, Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia. Blood Cell Therapy, 2022. 5(4): p. S25-S33.
  52. Nishikubo, M., N. Hiramoto, D. Yamashita, H. Imoto, Y. Sato, Y. Okuno, H. Haga, Y. Nannya, S. Ogawa, H. Kimura, and T. Ishikawa, Elderly-onset systemic Epstein-Barr virus-positive T-cell lymphoma of childhood. Pathol Int, 2022. 72(7): p. 376-378.
  53. Nishiwaki, S., Y. Akahoshi, M. Morita-Fujita, H. Shimizu, N. Uchida, Y. Ozawa, T. Fukuda, M. Tanaka, K. Ikegame, S. Ota, Y. Katayama, S. Takahashi, T. Kawakita, T. Ara, M. Onizuka, T. Kimura, J. Tanaka, Y. Atsuta, and Y. Arai, Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades. Blood Adv, 2022. 6(15): p. 4558-4569.
  54. Okada, Y., H. Nakasone, T. Konuma, N. Uchida, M. Tanaka, Y. Sugio, N. Aotsuka, A. Nishijima, Y. Katsuoka, T. Ara, S. Ota, M. Onizuka, M. Sawa, T. Kimura, T. Fukuda, Y. Atsuta, J. Kanda, and F. Kimura, Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation. Transplant Cell Ther, 2022. 28(8): p. 504 e1-504 e7.
  55. Sahara, N., K. Yokoyama, T. Matsunaga, S. Kitahara, T. Fujii, S. Kobayashi, N. Yusa, E. Shimizu, S. Imoto, A. Tojo, and N. Ohno, Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses. Leuk Res Rep, 2022. 18: p. 100348.
  56. Saito, K., T. Sato, K. Notohara, Y. Nannya, S. Ogawa, and Y. Ueda, Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated NPM1 and TET2. Intern Med, 2022. 61(21): p. 3265-3269.
  57. Sakurai, M., Y. Nannya, R. Yamazaki, K. Yamaguchi, Y. Koda, R. Abe, K. Yokoyama, S. Ogawa, and T. Mori, Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies. Ann Hematol, 2022. 101(1): p. 237-239.
  58. Salama, Y., S. Takahashi, Y. Tsuda, Y. Okada, K. Hattori, and B. Heissig, YO2 Induces Melanoma Cell Apoptosis through p53-Mediated LRP1 Downregulation. Cancers (Basel), 2022. 15(1).
  59. Shibata, S., S. Inano, M. Watanabe, K. Fujiwara, H. Ueno, Y. Nannya, J. Kanda, N. Kawasaki, Y. Okamoto, Y. Takiuchi, A. Fukunaga, S. Tabata, S. Ogawa, A. Takaori-Kondo, and T. Kitano, Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia. Int J Hematol, 2022. 115(3): p. 428-434.
  60. Shimomura, Y., T. Sobue, S. Hirabayashi, T. Kondo, S. Mizuno, J. Kanda, T. Fujino, K. Kataoka, N. Uchida, T. Eto, S. Miyakoshi, M. Tanaka, T. Kawakita, H. Yokoyama, N. Doki, K. Harada, A. Wake, S. Ota, S. Takada, S. Takahashi, T. Kimura, M. Onizuka, T. Fukuda, Y. Atsuta, and M. Yanada, Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia. Leukemia, 2022. 36(4): p. 1132-1138.
  61. Tachibana, T., T. Kondo, N. Uchida, N. Doki, S. Takada, S. Takahashi, S. Yano, T. Mori, A. Kohno, T. Kimura, T. Fukuda, Y. Atsuta, T. Nagamura-Inoue, and C.w.g.o.t.J.S.f.T.a.C.T. Adult, The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther, 2022. 28(6): p. 321 e1-321 e8.
  62. Takano, K., T. Konuma, M. Monna-Oiwa, M. Isobe, S. Kato, S. Takahashi, and Y. Nannya, Prognostic impact of switching from cyclosporine to corticosteroids early after single cord blood transplantation. Ann Hematol, 2022. 101(10): p. 2377-2378.
  63. Takeda, J., K. Yoshida, M.M. Nakagawa, Y. Nannya, A. Yoda, R. Saiki, Y. Ochi, L. Zhao, R. Okuda, X. Qi, T. Mori, A. Kon, K. Chiba, H. Tanaka, Y. Shiraishi, M.C. Kuo, C.M. Kerr, Y. Nagata, D. Morishita, N. Hiramoto, A. Hangaishi, H. Nakazawa, K. Ishiyama, S. Miyano, S. Chiba, Y. Miyazaki, T. Kitano, K. Usuki, N. Sezaki, H. Tsurumi, S. Miyawaki, J.P. Maciejewski, T. Ishikawa, K. Ohyashiki, A. Ganser, M. Heuser, F. Thol, L.Y. Shih, A. Takaori-Kondo, H. Makishima, and S. Ogawa, Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia. Blood Cancer Discov, 2022. 3(5): p. 410-427.
  64. Takeda, R., K. Yokoyama, T. Fukuyama, T. Kawamata, M. Ito, N. Yusa, R. Kasajima, E. Shimizu, N. Ohno, K. Uchimaru, R. Yamaguchi, S. Imoto, S. Miyano, and A. Tojo, Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review. Front Oncol, 2022. 12: p. 799982.
  65. Takeuchi, Y., K. Yoshida, A. Halik, A. Kunitz, H. Suzuki, N. Kakiuchi, Y. Shiozawa, A. Yokoyama, Y. Inoue, T. Hirano, T. Yoshizato, K. Aoki, Y. Fujii, Y. Nannya, H. Makishima, B.M. Pfitzner, L. Bullinger, M. Hirata, K. Jinnouchi, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, T. Okamoto, H. Haga, S. Ogawa, and F. Damm, The landscape of genetic aberrations in myxofibrosarcoma. Int J Cancer, 2022. 151(4): p. 565-577.
  66. Tanaka, Y., R. Takeda, T. Fukushima, K. Mikami, S. Tsuchiya, M. Tamura, K. Adachi, T. Umemoto, S. Asada, N. Watanabe, S. Morishita, M. Imai, M. Nagata, M. Araki, H. Takizawa, T. Fukuyama, C. Lamagna, E.S. Masuda, R. Ito, S. Goyama, N. Komatsu, T. Takaku, and T. Kitamura, Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors. Nat Commun, 2022. 13(1): p. 271.
  67. Vanni, D., O. Borsani, Y. Nannya, E. Sant'Antonio, C. Trotti, I.C. Casetti, D. Pietra, A. Galli, S. Zibellini, V.V. Ferretti, L. Malcovati, S. Ogawa, L. Arcaini, and E. Rumi, Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms. EJHaem, 2022. 3(2): p. 475-479.
  68. Wada, F., M. Watanabe, T. Konuma, M. Okabe, S. Kobayashi, N. Uchida, K. Ikegame, M. Tanaka, Y. Sugio, J. Mukae, M. Onizuka, T. Kawakita, T. Kuriyama, S. Takahashi, T. Fukuda, N. Nakano, M. Sawa, T. Kimura, T. Ichinohe, Y. Atsuta, J. Kanda, and T. Donor/Source Working Group of the Japan Society for Hematopoietic Cell, HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation. Am J Hematol, 2022. 97(3): p. 311-321.
  69. Wang, Q.S., R. Edahiro, H. Namkoong, T. Hasegawa, Y. Shirai, K. Sonehara, H. Tanaka, H. Lee, R. Saiki, T. Hyugaji, E. Shimizu, K. Katayama, M. Kanai, T. Naito, N. Sasa, K. Yamamoto, Y. Kato, T. Morita, K. Takahashi, N. Harada, T. Naito, M. Hiki, Y. Matsushita, H. Takagi, M. Ichikawa, A. Nakamura, S. Harada, Y. Sandhu, H. Kabata, K. Masaki, H. Kamata, S. Ikemura, S. Chubachi, S. Okamori, H. Terai, A. Morita, T. Asakura, J. Sasaki, H. Morisaki, Y. Uwamino, K. Nanki, S. Uchida, S. Uno, T. Nishimura, T. Ishiguro, T. Isono, S. Shibata, Y. Matsui, C. Hosoda, K. Takano, T. Nishida, Y. Kobayashi, Y. Takaku, N. Takayanagi, S. Ueda, A. Tada, M. Miyawaki, M. Yamamoto, E. Yoshida, R. Hayashi, T. Nagasaka, S. Arai, Y. Kaneko, K. Sasaki, E. Tagaya, M. Kawana, K. Arimura, K. Takahashi, T. Anzai, S. Ito, A. Endo, Y. Uchimura, Y. Miyazaki, T. Honda, T. Tateishi, S. Tohda, N. Ichimura, K. Sonobe, C.T. Sassa, J. Nakajima, Y. Nakano, Y. Nakajima, R. Anan, R. Arai, Y. Kurihara, Y. Harada, K. Nishio, T. Ueda, M. Azuma, R. Saito, T. Sado, Y. Miyazaki, R. Sato, Y. Haruta, T. Nagasaki, Y. Yasui, Y. Hasegawa, Y. Mutoh, T. Kimura, T. Sato, R. Takei, S. Hagimoto, Y. Noguchi, Y. Yamano, H. Sasano, S. Ota, Y. Nakamori, K. Yoshiya, F. Saito, T. Yoshihara, D. Wada, H. Iwamura, S. Kanayama, S. Maruyama, T. Yoshiyama, K. Ohta, H. Kokuto, H. Ogata, Y. Tanaka, K. Arakawa, M. Shimoda, T. Osawa, H. Tateno, I. Hase, S. Yoshida, S. Suzuki, M. Kawada, H. Horinouchi, F. Saito, K. Mitamura, M. Hagihara, J. Ochi, T. Uchida, R. Baba, D. Arai, T. Ogura, H. Takahashi, S. Hagiwara, G. Nagao, S. Konishi, I. Nakachi, K. Murakami, M. Yamada, H. Sugiura, H. Sano, S. Matsumoto, N. Kimura, Y. Ono, H. Baba, Y. Suzuki, S. Nakayama, K. Masuzawa, S. Namba, T. Shiroyama, Y. Noda, T. Niitsu, Y. Adachi, T. Enomoto, S. Amiya, R. Hara, Y. Yamaguchi, T. Murakami, T. Kuge, K. Matsumoto, Y. Yamamoto, M. Yamamoto, M. Yoneda, K. Tomono, K. Kato, H. Hirata, Y. Takeda, H. Koh, T. Manabe, Y. Funatsu, F. Ito, T. Fukui, K. Shinozuka, S. Kohashi, M. Miyazaki, T. Shoko, M. Kojima, T. Adachi, M. Ishikawa, K. Takahashi, T. Inoue, T. Hirano, K. Kobayashi, H. Takaoka, K. Watanabe, N. Miyazawa, Y. Kimura, R. Sado, H. Sugimoto, A. Kamiya, N. Kuwahara, A. Fujiwara, T. Matsunaga, Y. Sato, T. Okada, Y. Hirai, H. Kawashima, A. Narita, K. Niwa, Y. Sekikawa, K. Nishi, M. Nishitsuji, M. Tani, J. Suzuki, H. Nakatsumi, T. Ogura, H. Kitamura, E. Hagiwara, K. Murohashi, H. Okabayashi, T. Mochimaru, S. Nukaga, R. Satomi, Y. Oyamada, N. Mori, T. Baba, Y. Fukui, M. Odate, S. Mashimo, Y. Makino, K. Yagi, M. Hashiguchi, J. Kagyo, T. Shiomi, S. Fuke, H. Saito, T. Tsuchida, S. Fujitani, M. Takita, D. Morikawa, T. Yoshida, T. Izumo, M. Inomata, N. Kuse, N. Awano, M. Tone, A. Ito, Y. Nakamura, K. Hoshino, J. Maruyama, H. Ishikura, T. Takata, T. Odani, M. Amishima, T. Hattori, Y. Shichinohe, T. Kagaya, T. Kita, K. Ohta, S. Sakagami, K. Koshida, K. Hayashi, T. Shimizu, Y. Kozu, H. Hiranuma, Y. Gon, N. Izumi, K. Nagata, K. Ueda, R. Taki, S. Hanada, K. Kawamura, K. Ichikado, K. Nishiyama, H. Muranaka, K. Nakamura, N. Hashimoto, K. Wakahara, S. Koji, N. Omote, A. Ando, N. Kodama, Y. Kaneyama, S. Maeda, T. Kuraki, T. Matsumoto, K. Yokote, T.A. Nakada, R. Abe, T. Oshima, T. Shimada, M. Harada, T. Takahashi, H. Ono, T. Sakurai, T. Shibusawa, Y. Kimizuka, A. Kawana, T. Sano, C. Watanabe, R. Suematsu, H. Sageshima, A. Yoshifuji, K. Ito, S. Takahashi, K. Ishioka, M. Nakamura, M. Masuda, A. Wakabayashi, H. Watanabe, S. Ueda, M. Nishikawa, Y. Chihara, M. Takeuchi, K. Onoi, J. Shinozuka, A. Sueyoshi, Y. Nagasaki, M. Okamoto, S. Ishihara, M. Shimo, Y. Tokunaga, Y. Kusaka, T. Ohba, S. Isogai, A. Ogawa, T. Inoue, S. Fukuyama, Y. Eriguchi, A. Yonekawa, O.K. Kan, K. Matsumoto, K. Kanaoka, S. Ihara, K. Komuta, Y. Inoue, S. Chiba, K. Yamagata, Y. Hiramatsu, H. Kai, K. Asano, T. Oguma, Y. Ito, S. Hashimoto, M. Yamasaki, Y. Kasamatsu, Y. Komase, N. Hida, T. Tsuburai, B. Oyama, M. Takada, H. Kanda, Y. Kitagawa, T. Fukuta, T. Miyake, S. Yoshida, S. Ogura, S. Abe, Y. Kono, Y. Togashi, H. Takoi, R. Kikuchi, S. Ogawa, T. Ogata, S. Ishihara, A. Kanehiro, S. Ozaki, Y. Fuchimoto, S. Wada, N. Fujimoto, K. Nishiyama, M. Terashima, S. Beppu, K. Yoshida, O. Narumoto, H. Nagai, N. Ooshima, M. Motegi, A. Umeda, K. Miyagawa, H. Shimada, M. Endo, Y. Ohira, M. Watanabe, S. Inoue, A. Igarashi, M. Sato, H. Sagara, A. Tanaka, S. Ohta, T. Kimura, Y. Shibata, Y. Tanino, T. Nikaido, H. Minemura, Y. Sato, Y. Yamada, T. Hashino, M. Shinoki, H. Iwagoe, H. Takahashi, K. Fujii, H. Kishi, M. Kanai, T. Imamura, T. Yamashita, M. Yatomi, T. Maeno, S. Hayashi, M. Takahashi, M. Kuramochi, I. Kamimaki, Y. Tominaga, T. Ishii, M. Utsugi, A. Ono, T. Tanaka, T. Kashiwada, K. Fujita, Y. Saito, M. Seike, H. Watanabe, H. Matsuse, N. Kodaka, C. Nakano, T. Oshio, T. Hirouchi, S. Makino, M. Egi, Y. Omae, Y. Nannya, T. Ueno, T. Takano, K. Katayama, M. Ai, A. Kumanogoh, T. Sato, N. Hasegawa, K. Tokunaga, M. Ishii, R. Koike, Y. Kitagawa, A. Kimura, S. Imoto, S. Miyano, S. Ogawa, T. Kanai, K. Fukunaga and Y. Okada, The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun, 2022. 13(1): p. 4830.
  70. Watanabe, K., S. Kimura, M. Seki, T. Isobe, Y. Kubota, M. Sekiguchi, A. Sato-Otsubo, M. Hiwatari, M. Kato, A. Oka, K. Koh, Y. Sato, H. Tanaka, S. Miyano, T. Kawai, K. Hata, H. Ueno, Y. Nannya, H. Suzuki, K. Yoshida, Y. Fujii, G. Nagae, H. Aburatani, S. Ogawa, and J. Takita, Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism. Oncogene, 2022. 41(46): p. 4994-5007.
  71. Wong, S.Y., S. Kato, F. Rodenburg, A. Tojo, and N. Hayashi, Longitudinal proteomics study of serum changes after allogeneic HSCT reveals potential markers of metabolic complications related to aGvHD. Sci Rep, 2022. 12(1): p. 14002.
  72. Yanada, M., K. Harada, Y. Shimomura, Y. Arai, and T. Konuma, Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies. Front Oncol, 2022. 12: p. 1050633.
  73. Yanada, M., S. Yamasaki, T. Konuma, S. Mizuno, N. Uchida, D. Onai, T. Fukuda, M. Tanaka, Y. Ozawa, T. Eto, K. Ikegame, M. Sawa, Y. Katayama, T. Kawakita, M. Onizuka, Y. Kanda, T. Ichinohe, Y. Atsuta, and S. Yano, Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. Int J Hematol, 2022.
  74. Yasuda, T., M. Sanada, M. Kawazu, S. Kojima, S. Tsuzuki, H. Ueno, E. Iwamoto, Y. Iijima-Yamashita, T. Yamada, T. Kanamori, R. Nishimura, Y. Kuwatsuka, S. Takada, M. Tanaka, S. Ota, N. Dobashi, E. Yamazaki, A. Hirose, T. Murayama, M. Sumi, S. Sato, N. Tange, Y. Nakamura, Y. Katsuoka, E. Sakaida, T. Kawamata, H. Iida, Y. Shiraishi, Y. Nannya, S. Ogawa, M. Taniwaki, N. Asou, Y. Hatta, H. Kiyoi, I. Matsumura, K. Horibe, H. Mano, T. Naoe, Y. Miyazaki, and F. Hayakawa, Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations. Blood, 2022. 139(12): p. 1850-1862.
  75. Yokoyama, H., M. Kanaya, T. Iemura, M. Hirayama, S. Yamasaki, T. Kondo, N. Uchida, S. Takahashi, M. Tanaka, M. Onizuka, Y. Ozawa, Y. Kozai, T. Eto, Y. Sugio, A. Hamamura, T. Kawakita, N. Aotsuka, S. Takada, A. Wake, T. Kimura, T. Ichinohe, Y. Atsuta, M. Yanada, and S. Morishima, Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch. Bone Marrow Transplant, 2022. 57(7): p. 1171-1179.
  76. Yoshihara, K., Y. Nannya, I. Matsuda, M. Samori, N. Utsunomiya, M. Okada, S. Hirota, S. Ogawa, and S. Yoshihara, T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. EJHaem, 2022. 3(1): p. 211-214.

Back to top ↑

Publications

2021

  1. Fujii, Y., Y. Sato, H. Suzuki, N. Kakiuchi, T. Yoshizato, A.T. Lenis, S. Maekawa, A. Yokoyama, Y. Takeuchi, Y. Inoue, Y. Ochi, Y. Shiozawa, K. Aoki, K. Yoshida, K. Kataoka, M.M. Nakagawa, Y. Nannya, H. Makishima, J. Miyakawa, T. Kawai, T. Morikawa, Y. Shiraishi, K. Chiba, H. Tanaka, G. Nagae, M. Sanada, E. Sugihara, T.A. Sato, T. Nakagawa, M. Fukayama, T. Ushiku, H. Aburatani, S. Miyano, J.A. Coleman, Y. Homma, D.B. Solit, H. Kume, and S. Ogawa, Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell, 2021. 39(6): p. 793-809 e8.
  2. Fujishima, N., J. Kohmaru, S. Koyota, K. Kuba, T. Saga, A. Omokawa, Y. Moritoki, S. Ueki, F. Ishida, S. Nakao, A. Matsuda, A. Ohta, K. Tohyama, H. Yamasaki, K. Usuki, Y. Nakashima, S. Sato, Y. Miyazaki, Y. Nannya, S. Ogawa, K. Sawada, K. Mitani, and M. Hirokawa, Clonal hematopoiesis in adult pure red cell aplasia. Sci Rep, 2021. 11(1): p. 2253.
  3. Hirama, T., S. Tokita, M. Nakatsugawa, K. Murata, Y. Nannya, K. Matsuo, H. Inoko, Y. Hirohashi, S. Hashimoto, S. Ogawa, I. Takemasa, N. Sato, F. Hata, T. Kanaseki, and T. Torigoe, Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue. JCI Insight, 2021. 6(14).
  4. Klimkowska, M., Y. Nannya, C. Gran, R. Mansson, I. Douagi, S. Ogawa, H. Nahi, and M. Tobiasson, Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder. Blood, 2021. 137(9): p. 1260-1263.
  5. Kuwada, T., M. Shiokawa, Y. Kodama, S. Ota, N. Kakiuchi, Y. Nannya, H. Yamazaki, H. Yoshida, T. Nakamura, S. Matsumoto, Y. Muramoto, S. Yamamoto, Y. Honzawa, K. Kuriyama, K. Okamoto, T. Hirano, H. Okada, S. Marui, Y. Sogabe, T. Morita, T. Matsumori, A. Mima, Y. Nishikawa, T. Ueda, K. Matsumura, N. Uza, T. Chiba, and H. Seno, Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients With Ulcerative Colitis. Gastroenterology, 2021. 160(7): p. 2383-2394 e21.
  6. Momose, A., S. Yamaguchi, A. Okada, K. Ikeda-Kurakawa, D. Namiki, Y. Nannya, H. Kato, T. Yamauchi, M. Nangaku, and T. Kadowaki, Factors associated with long-term care certification in older adults: a cross-sectional study based on a nationally representative survey in Japan. BMC Geriatr, 2021. 21(1): p. 374.
  7. Momose, H., H. Nishikii, Y. Kozuma, I. Ota-Tsutsumi, Y. Nannya, C. Yoshida, T. Komeno, M. Kusakabe, Y. Yokoyama, T. Kato, N. Kurita, A. Sootome, M. Sakata-Yanagimoto, N. Obara, Y. Hasegawa, S. Ogawa, and S. Chiba, [Acquired platelet dysfunction with severe bleeding tendency in triple-negative myelofibrosis]. Rinsho Ketsueki, 2021. 62(9): p. 1406-1411.
  8. Murakami, K., Y. Yamaguchi, Y. Kida, Y. Morikawa, H. Ujiie, H. Sugahara, Y. Nannya, S. Ogawa, and Y. Kanakura, Clonal Cytopenia of Undetermined Significance in a Patient with Congenital Wilms' Tumor 1 and Acquired DNMT3A Gene Mutations. Intern Med, 2021. 60(23): p. 3785-3788.
  9. Nakamura, F., H. Arai, Y. Nannya, M. Ichikawa, S. Furuichi, F. Nagasawa, W. Takahashi, T. Handa, Y. Nakamura, H. Tanaka, Y. Nakamura, K. Sasaki, S. Miyano, S. Ogawa, and K. Mitani, Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy. Int J Hematol, 2021. 113(6): p. 936-940.
  10. Ochi, Y., K. Yoshida, Y.J. Huang, M.C. Kuo, Y. Nannya, K. Sasaki, K. Mitani, N. Hosoya, N. Hiramoto, T. Ishikawa, S. Branford, N. Shanmuganathan, K. Ohyashiki, N. Takahashi, T. Takaku, S. Tsuchiya, N. Kanemura, N. Nakamura, Y. Ueda, S. Yoshihara, R. Bera, Y. Shiozawa, L. Zhao, J. Takeda, Y. Watatani, R. Okuda, H. Makishima, Y. Shiraishi, K. Chiba, H. Tanaka, M. Sanada, A. Takaori-Kondo, S. Miyano, S. Ogawa, and L.Y. Shih, Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia. Nat Commun, 2021. 12(1): p. 2833.
  11. Okamoto, H., N. Uoshima, Y. Kamitsuji, E. Kawata, Y. Komori, N. Sasaki, Y. Tsutsumi, T. Tsukamoto, S. Mizutani, Y. Nannya, and J. Kuroda, Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations. Ann Hematol, 2021. 100(8): p. 2113-2115.
  12. Saiki, R., Y. Momozawa, Y. Nannya, M.M. Nakagawa, Y. Ochi, T. Yoshizato, C. Terao, Y. Kuroda, Y. Shiraishi, K. Chiba, H. Tanaka, A. Niida, S. Imoto, K. Matsuda, T. Morisaki, Y. Murakami, Y. Kamatani, S. Matsuda, M. Kubo, S. Miyano, H. Makishima, and S. Ogawa, Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis. Nat Med, 2021. 27(7): p. 1239-1249.
  13. Sasaki, K., Y. Nannya, Y. Nakamura, M. Ichikawa, S. Ogawa, and K. Mitani, Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation. Hematology, 2021. 26(1): p. 594-600.
  14. Shimada, K., K. Yoshida, Y. Suzuki, C. Iriyama, Y. Inoue, M. Sanada, K. Kataoka, M. Yuge, Y. Takagi, S. Kusumoto, Y. Masaki, T. Ito, Y. Inagaki, A. Okamoto, Y. Kuwatsuka, M. Nakatochi, S. Shimada, H. Miyoshi, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, Y. Shiozawa, Y. Nannya, A. Okabe, K. Kohno, Y. Atsuta, K. Ohshima, S. Nakamura, S. Ogawa, A. Tomita, and H. Kiyoi, Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma. Blood, 2021. 137(11): p. 1491-1502.
  15. Shimizu, T., T. Kondo, Y. Nannya, M. Watanabe, T. Kitawaki, T. Shindo, M. Hishizawa, K. Yamashita, S. Ogawa, and A. Takaori-Kondo, Next-generation sequencing in two cases of de novo acute basophilic leukaemia. J Cell Mol Med, 2021. 25(14): p. 7095-7099.
  16. Todisco, G., M. Creignou, A. Galli, P. Guglielmelli, E. Rumi, M. Roncador, E. Rizzo, Y. Nannya, D. Pietra, C. Elena, E. Bono, E. Molteni, V. Rosti, S. Catricala, M. Sarchi, M. Dimitriou, J. Ungerstedt, A.M. Vannucchi, E. Hellstrom-Lindberg, S. Ogawa, M. Cazzola, and L. Malcovati, Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2(P95)-mutated neoplasms. Leukemia, 2021. 35(8): p. 2371-2381.
  17. Wada, F., N. Hiramoto, D. Yamashita, S. Hara, Y. Furukawa, J. Ishii, K. Nagata, Y. Nannya, S. Ogawa, and T. Ishikawa, Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAF(V600E) mutation. Am J Hematol, 2021. 96(8): p. E295-E298.
  18. Yamamoto, K., S. Goyama, S. Asada, T. Fujino, T. Yonezawa, N. Sato, R. Takeda, A. Tsuchiya, T. Fukuyama, Y. Tanaka, A. Yokoyama, H. Toya, A. Kon, Y. Nannya, R. Onoguchi-Mizutani, S. Nakagawa, T. Hirose, S. Ogawa, N. Akimitsu, and T. Kitamura, A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells. Cell Rep, 2021. 36(8): p. 109576.
  19. Yasu, T., T. Konuma, M. Oiwa-Monna, S. Takahashi, Y. Nannya, and A. Tojo, Hematological effects on peri-transplant use of linezolid in adults undergoing single-unit cord blood transplantation. Ann Hematol, 2021. 100(11): p. 2867-2869.
  20. Yoroidaka, T., K. Hosokawa, T. Imi, H. Mizumaki, T. Katagiri, K. Ishiyama, H. Yamazaki, F. Azuma, Y. Nanya, S. Ogawa, and S. Nakao, Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia. Leukemia, 2021.

Back to top ↑

Back to Research